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Abstract

Association of Hypertension Perceptions and Antihypertensive Medication Adherence
Among Black Hypertensive Adults in Primary Care Settings.
By Stella Eke, DNP, RN, FNP-C
May, 2018
Black adults with hypertension are more likely to have uncontrolled hypertension
and suffer more complications than Whites, partially due to decreased medication
adherence among Black patients. Several studies have found that Black adults with
hypertension have numerous misconceptions about it and its management; however, few
studies have examined hypertension perceptions in relation to antihypertensive
medication adherence.
Using the common-sense model of perception and self-regulation of illness as the
theoretical framework, this cross-sectional study aimed to investigate the relationship
between hypertension perceptions and medication adherence among Black hypertensive
adults 35 to 65 years old in primary care settings. It also examined the factor structure of
hypertension causal attributions and explores gender differences in hypertension
perceptions and medication adherence.
A nonprobability sample of 118 Black hypertensive adults 35 to 65 years old was
selected as they presented in four primary care clinics. Instruments included the revised
Illness Perception Questionnaire (IPQ-R) and the Hill-Bone Blood Pressure Therapy
Compliance Scale.
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The sample was middle aged (M = 53.9; SD = 7.9 years), 52.5% male, and mostly
educated, with 51% having a four-year college degree or higher. Using principal
components factor analysis, two factors emerged, which explained 40.8% variance in
causal attributions: items related to unhealthy lifestyle choices and factors outside the
individual’s control, and items related to life stressors and known predisposing factors for
hypertension. Using multiple regression while controlling for covariates, three IPQ-R
subscales (Cyclical Timeline, Consequences, and Emotional Representation) explained
23.9% variance in medication adherence, F (6, 111) = 5.82, p < .001; however, only
Consequences had a significant relationship with medication adherence (p = .022). Using
ANCOVA, only one of the subscales had a significant gender difference; males had
higher (p = .034) adjusted mean scores (M = 16.2, SE = .64.) than females (M = 14.2, SE
= .67) for the perception that hypertension is caused by unhealthy lifestyle choices and
factors outside an individual’s control.
Although these findings could be applied to similar patient populations in primary
care, variation in antihypertensive medication adherence is largely unexplained and needs
further research. A longitudinal study with a larger sample size could further examine
and clarify hypertension beliefs among Black hypertensive adults.
Keywords: Illness perceptions, medication, adherence, Black hypertensive adults.
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1
Summary of Study

The focus of this observational cross-sectional study was to examine the
association between perceptions about hypertension and medication adherence among
Black hypertensive adults 35 to 65 years of age in primary care settings. An additional
focus was to investigate the causal attributions of hypertension as well as explore any
gender differences in hypertension perceptions and medication adherence.
The study was conducted as outlined in the proposal, and the aims, methods,
analyses, and results reflect the content of the study proposal. There was no deviation
from the proposal. The proposal outlines the specific aims, significance of the problem,
proposed methods, and analyses, while the manuscript outlines the execution of the
study, outlining the procedures, analyses, results, and discussion.
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Proposal

Introduction
Cardiovascular disease (CVD) remains the leading cause of death in the United
States (American Heart Association [AHA], 2015). Furthermore, the AHA (2017a)
reported that among Black adults 20 years and older, 46% of males and 47.7% of females
have CVD. CVD caused the death of 49,210 Black males and 48,573 Black females in
2014 (AHA, 2017a). Hypertension (HTN) is the leading cause of CVD (Valderrama,
Gillespie, & Mercado, 2013). Among non-Hispanic Blacks aged 20 years and older, 45%
of males and 46.3% of females have hypertension (AHA, 2017b). Uncontrolled
hypertension is considered an important risk factor for coronary heart disease, stroke,
congestive heart failure, end-stage renal disease, and peripheral vascular disease (AHA,
2017a; Sulainman et al., 2009). Compared with Whites, Blacks develop hypertension
earlier, have higher average blood pressure and poorer blood pressure control, causing
Blacks with hypertension to have 1.3 times greater rate of nonfatal stroke, 1.8 times
greater rate of fatal stroke, 1.5 times greater rate of heart disease death, 4.2 times greater
rate of end-stage kidney disease, and 50% higher frequency of heart failure (AHA, 2015;
Go et al., 2014).
Although 80.8% of Blacks are aware of their hypertension, and 71.9% are under
treatment, only 43% have their hypertension under control (Valderrama & Gillespie, 2013).
Black adults are more likely to be non-adherent to antihypertensive medications or have
uncontrolled hypertension than other races (Dickinson & Plauschinat, 2008; Redmond, Baer,
& Hicks, 2011; Bosworth et al., 2006). Shaya et al. (2009) reported that Black hypertensive
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adults on Medicaid were 50% less adherent to medications than Whites; another longitudinal
cohort study among hypertensive Medicaid recipients found that African American patients
were less adherent to medications than Whites (55% vs. 61%, p < .05) (Dickson &
Plauschinat, 2008).
Having a better understanding of the critical factors impeding medication
adherence and hypertension among Black hypertensive adults will inform the design of
meaningful interventions to curtail the alarming burden of uncontrolled hypertension
among Blacks. Factors affecting medication adherence among Black hypertensive adults
seem to be multifaceted. A systematic review by Lewis (2012) explored several factors
theorized by researchers to impact medication adherence among Blacks, including
healthcare system, nature of hypertension as an often-non-symptomatic disease, treatment
complexity, presence of other comorbidities, and patient-related issues. Furthermore,
numerous qualitative studies have found that Black adults have misconceptions about
hypertension (Ogedegbe et al., 2004; Lukoschek, 2003; Wilson et al., 2002), but only a
few studies have explored the relationship between these misconceptions and medication
adherence (Heckler et al., 2008; Heurtin-Roberts & Resisin, 1990).
The main objective of the current study is to explore whether there is an
association between hypertension perceptions and medication adherence among Black
hypertensive adults after controlling for certain factors that affect medication adherence
and illness perceptions and, furthermore, to investigate participants’ perceptions about
causes of their hypertension. Additionally, the present study intends to explore whether
there are gender differences in hypertension perceptions. Most of the existing knowledge
about hypertension perceptions among Black adults is based on studies with majority-
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female samples. The long-term goal and research trajectory will focus on designing a
theory-based randomized clinical trial using intervention strategies that promote better
understanding of hypertension, medication adherence, and blood pressure control among
Black hypertensive adults.
The central hypothesis in the present study is that perceptions about hypertension
as it relates to disease timeline, controllability, consequences, emotional representation,
illness coherence, and cause will be associated with medication adherence among Black
hypertensive adults aged 35 to 65 years old being treated for hypertension in primary care
settings.

Specific Aims and Hypotheses
Aim #1: To investigate participants’ perceptions about causes of hypertension.
Hypothesis #1: Compared to other factors, perception of psychological factors as a cause
of hypertension will explain the highest variance in views about the cause of
hypertension.
Aim #2: To examine the relationship between medication adherence and hypertension
perceptions as related to views about hypertension timeline, controllability,
consequences, emotional representation, illness coherence, and cause among Black
hypertensive adults 35 to 65 years old, while controlling for depression, educational
level, duration of diagnosis, hypertension-related symptom, and severity of hypertension.
Hypothesis #2: There will be a statistically significant relationship between medication
adherence and hypertension perceptions.
Aim #3: To explore to what extent hypertension perceptions and medication adherence
differ by gender after controlling for confounders.
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Background and Significance
When compared to Whites, Blacks develop hypertension earlier, have higher
average blood pressure, and have poorer blood pressure control—all of which lead to
Blacks with hypertension having a 1.3 times greater rate of nonfatal stroke, 1.8 times
greater rate of fatal stroke, 1.5 times greater rate of heart disease death, 4.2 times greater
rate of end-stage kidney disease, and a 50% higher frequency of heart failure (Go et al.,
2014). In addition, 30-year mortality risk among White hypertensive men was 23.8%
compared to 45.2% from Black hypertensive men, and 18.3% for White women
compared to 39.5% for Black women (Lackland, 2014). Non-Hispanic Blacks had 90%
higher odds of poorly controlled hypertension compared to non-Hispanic Whites, even
after controlling for socioeconomic status, gender, age, and other clinical factors
(Redmond, Baer & Hicks, 2011). Even though there has been advancement in treatment
options for hypertension and other cardiovascular disease risk factors over the years,
uncontrolled hypertension remains a public health burden in the United States
(Mozaffana et al., 2015; Chobanian, 2015). Furthermore, Chobanian (2015) asserts that
evidence has shown that these advanced antihypertensive options are effective in
controlling hypertension in anyone, irrespective of race. Nevertheless, only 43% of
Black hypertensive adults have their blood pressure under control (Valderrama &
Gillespie, 2013).
Studies have noted that even Black hypertensive adults on government-sponsored
insurance, such as Medicaid, are less adherent to antihypertensive medication compared
to their White counterparts. Shaya et al. (2009) examined predictors of antihypertensive
therapy adherence among 568 Medicaid hypertensive patients and found that Blacks were

6
50% less adherent to medication compared to their White counterparts; additionally,
another study by Dickson and Plauschinat (2008) reported a significant difference in
medication adherence among Black hypertensive adults compared to Whites (55% vs.
61%; p < .05).
The AHA projects cost of medical care for hypertension will increase from $69.9
billion in 2010 to $200.3 billion in 2030 (Heidenreich, 2011), while the Center for
Disease Control and Prevention ([CDC], 2016) reports that hypertension costs $48.6
billion yearly. According to the Agency for Healthcare Research and Quality ([AHRQ],
2013), in 2010 direct medical expenditure for hypertension totaled 42.9 billion, with a
higher percentage of non-Hispanic Blacks (30.4%) being treated for hypertension than
non-Hispanic Whites (26.7%); furthermore, annual expenditure for those treated for
hypertension averaged $733 per adult, while mean expenditure per person with
hypertension was $887 for Blacks, compared to $679 per person for non-Hispanic
Whites.
There is a need for future research to focus on populations with the highest
prevalence of uncontrolled hypertension and its complications (Levine et al., 2011). The
current study chose to focus on Black hypertensive adults, aged 35 to 65 years, because
this is about the age where the onset and prevalence of hypertension is generally high.
Although individuals start developing hypertension around middle age, Blacks develop
hypertension at an even younger age (CDC, 2016; AHA, 2016). Targeting hypertensive
patients within this age group (35 to 65 years) for interventions to improve understanding
of hypertension and promote medication adherence will help in forestalling potential
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future negative outcomes that could emanate from uncontrolled hypertension among
Black hypertensive adults.
The current study is focusing on Black hypertensive adults with a history of
primary hypertension for at least 12 months and who have ever been prescribed
antihypertensive medication or are currently taking at least one antihypertensive
medication. Restricting recruitment to patients within these parameters eliminates the
chance for including newly diagnosed hypertensives that have yet to comprehend or
adjust to their diagnoses or patients with borderline hypertension who may not have been
prescribed medication but are on lifestyle modification instead.
The World Health Organization ([WHO], 2003) defines medication adherence as
the extent to which a patient’s medication-taking behavior matches with agreed
recommendations from a healthcare provider. Medication adherence is further defined as
the degree to which a patient follows recommended or prescribed medications by their
healthcare providers as it relates to timing, dosing, and frequency (Cramer et al., 2008).
According to the WHO (2003), the patient should be considered an active collaborator in
their treatment rather than a passive recipient of advice from healthcare providers.
Medication non-adherence remains a problem among Black hypertensive adults.
The reason for medication non-adherence among Blacks seems complex and
multifaceted. Individual studies have outlined factors such as poor socioeconomic status,
distrust for physicians, racial discrimination, comorbidities, disease-related problems
(such as absence or presence of symptoms), complexity of medication regimen, patientprovider communication, depression, and a fatalistic view of hypertension (Greer, 2010;
Ndumele et al., 2010; Ogedegbe et al., 2003; Ogedegbe et al., 2004). In addition, a recent
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study with a majority-Black-hypertensive-adult sample noted that patient-provider
interaction that does not involve the patient or involve patients’ sociodemographic needs
often leads to poor medication adherence (Schoenthaler, Knafl, Fiscella, & Ogedegbe,
2017). As noted earlier, the most recent systematic review on factors affecting
medication adherence among Black hypertensive adults reported that medication
adherence or non-adherence was consistently associated with self-efficacy; depression;
patient-provider communication and system-related factors; disease-related factors, such
as presence or absence of symptoms; and severity of hypertension (Lewis, 2012).
Although several assertions have been made to explain the poor therapy
adherence among Black hypertensive patients, the solution to this problem remains
difficult and elusive (Kressin, Orner, Manze, Glickman, & Berlowitz, 2010). Most of the
existing interventions to address some of these problems have only yielded inconclusive
or non-promising results; thus, the need to explore other potential contributing factors,
such as illness perception.
Middleton (2009) suggested that the lower rates of adherence to prescribed
therapy for hypertension, including exercise, diet, and medication, among Black
hypertensive adults may be related to the inaccurate illness perceptions held about
hypertension that are not consistent with a biomedical disease model of hypertension.
Ross et al. (2004) discussed the effect of illness beliefs on predicting medication
adherence, and further reported that patients who do not perceive hypertension to be
serious may self-regulate their antihypertensive medications accordingly. The authors
further asserted that targeting patients’ health beliefs may be important in designing
interventions to improve adherence to antihypertensive therapy. A qualitative study with
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a sample of 19 African-American, 20 White, and nine Hispanic Veterans Administration
patients reported that among other factors, patients’ perceptions of the cause, course of
hypertension, and experiences of hypertension symptoms were linked with their reports
of their self-management behaviors (Bokhour et al., 2012). Furthermore, in a quantitative
study by Rajpura and Nayak (2014), with a sample that was made up of 76.9% Whites
and 18.8% Blacks, aged 55 years and older, more favorable perceptions of illness were
associated with higher medication adherence scores (p = .001). Several qualitative
studies have reported worrisome levels of misconceptions about hypertension among
Black hypertensive adults (Boutin-Foster, Ogedegbe, Ravenell, Robins, & Charlson,
2007; Ogedegbe, Mancuso, & Allegrante, 2004; Schlomann, & Schmitke, 2007; Wilson
et al., 2002).
Illness perception is conceptually defined as an individual’s beliefs or cognitive
understanding about an illness (Leventhal et al., 2003). A deeper understanding of illness
perception has been shown to be useful in assessing patients’ illness outcomes (Figueria
& Alves, 2006; Hagger & Orbell, 2003). When faced by a health threat, an individual
cognitively evaluates and tries to make sense of the health threat, after which the
individual is likely to develop a coping mechanism that is guided by the level of risk
perceived about the illness. These beliefs can be shaped by medical knowledge through
interaction with healthcare providers, personal experiences, and/or experiences of others,
such as family or friends (Petrie & Weinman, 2006). An individual that holds a
misguided perception or understanding about the cause, complications, timeline,
controllability/cure, and chronicity of hypertension is likely to be non-adherent to
prescribed medications.
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The self-regulation of health and illness model, also called the common-sense
model (Leventhal, Brissette, & Leventhal, 2003), serves as the theoretical guiding
framework for this study. This model emphasizes the role of illness perception in
guiding coping behaviors toward an illness, which subsequently affect illness outcomes.
The model proposes that in response to a health threat, individuals may develop both
parallel cognitive and emotional representations, which in turn give rise to problem-based
and emotional-focused coping behaviors (Leventhal et al., 2001). The authors assert that
response to illness involves three processes, namely representation, coping, and appraisal.
The model posits that the mental impressions patients attach to the identity
(symptoms), duration of illness, illness outcome/consequences, causal factors, and
curability guide their coping mechanism toward the illness. When faced with a health
threat, the individual tries to develop a cognitively reasoned understanding of the health
threat, eventually develops a coping mechanism based on personal mental representation
of the illness, and, finally, with time, appraises such coping mechanisms. In this study,
the coping behavior of interest is medication adherence versus non-adherence.
If a patient cognitively perceives an illness such as hypertension to be non-life
threatening, adherence to medication may be low. Furthermore, when an individual
perceives hypertension to be chronic, they may have a different behavioral plan on how
to manage or cope with the illness than when it is perceived to be episodic, acute, or
temporary.
The self-regulation of health and illness model identifies five constructs of illness
representation as follows (Leventhal et al., 2003):
1. Identity/Label (Symptoms)
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2. Timeline
3. Consequences
4. Cause
5. Control/Cure
Identity represents the label a patient assigns to personal symptoms or perception of
symptoms associated with the illness. Timeline represents the patient’s perception of the
duration of illness in terms of whether the illness is acute/temporary, chronic, or cyclical
in nature. Consequence signifies the level of threat or complications perceived to be
associated with the illness. Cause represents perceived etiology of the illness as it relates
to external or internal factors or stressors. Finally, Control or Cure represents what the
individual thinks about the controllability or curability of the illness by medication,
and/or whether he/she can do what is needed to control the disease.
This model fits very well into the present study in that patients with high blood
pressure often misconceive the disease as a non-life-threatening illness, especially due to
its mostly asymptomatic nature. A misguided view of hypertension may lead to nonadherence behavior with prescribed medication. This is particularly important among
Black adults as studies have reported that most Blacks attribute hypertension to stress and
often engage in stress-management activities to control hypertension at the expense of
medications (Heckler et al., 2008; Heurtin-Roberts, 1990; Rose, Kim, Dennison, & Hill,
2000; Wilson et al., 2002).
This problematic misconception of hypertension due to its mostly asymptomatic
nature has led some patients to question their diagnoses of hypertension and the need for
treatment for the disease (Schlomann, & Schmitke, 2007). Some patients with
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hypertension often adjust their medication based on symptoms, which may be very
deceiving since lack of symptoms does not necessarily indicate the absence of elevated
blood pressure or hypertension (Schlomann, & Schmitke, 2007)—thus the reason
hypertension is called a silent killer.
Literature review on perceptions about hypertension among Black hypertensive
adults. A qualitative study with a sample of 93 African-American hypertensive adults
reported that a good proportion of patients had nonbiomedical misconceived expectations
of their treatment, where 38% expected a cure for their hypertension, 38% did not expect
to take their medications for life, and 23% took medications only with symptoms
(Ogedegbe et al.2004). Boutin-Foster et al. (2007) conducted a qualitative study among a
sample of 60 African Americans with uncontrolled hypertension using structured
interviews. This study found that Black adults with family members who had
experienced complications from hypertension are more likely to perceive hypertension as
a serious disease, and, furthermore, those who experience symptoms from hypertension
and have family members with a history of hypertension were more likely to adhere to
recommended therapy to control their high blood pressure.
Some Blacks do not perceive hypertension as a disease arising from a
pathological process, but rather perceive it to be self-regulating and, thus, requiring no
medication or medical treatment. In addition, some view hypertension as an expected
adjustment to stressful life events (Lukoschek, 2003; Ogedegbe et al., 2004). A focus
group interview of 112 to 128 adherent and non-adherent low SES Black hypertensive
adults 30 to 65 years old revealed that some perceived hypertension to be a different
disease from high blood pressure, where hypertension can be cured since it is caused by
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stress and emotional state, while high blood pressure is caused by “thick blood and
arteries” and is not curable (Lukoschek, 2003). Furthermore, hypertension was also
perceived as a disease that always has symptoms. Wilson et al. (2002) investigated the
lay beliefs about high blood pressure among 167 Blacks, 18 to 74 years old. This study
found that some of the participants attributed high blood pressure to eating pork and other
foods that were perceived as making “blood travel fast to the head,” while some
described high blood pressure as “elevated blood vessels.” In addition, the authors noted
that some of the participants had the perception that high blood pressure can be cured
with vitamins, garlic, and herbs. In a qualitative study using a sample of 42 Black
hypertensive adults 30 to 65 years (66.7% women), Lukoschek (2003) reported that
participants believed that hypertension is a separate disease from high blood pressure,
where high blood pressure is a physiological disease while hypertension results from
emotional or psychological state. Another qualitative study using 47 Black women noted
that though hypertension is seen as a serious disease, the cause was attributed to
psychological stress (Webb & Gonzalez, 2006).
The literature search revealed that only a few studies have examined the
relationship between perceptions of hypertension and medication adherence among Black
hypertensive adults. An older study by Heurtin-Roberts and Reisin (1992) assessed the
relationship between lay beliefs about hypertension and medication adherence among 60
Black hypertensive women attending a public-hospital-based clinic in New Orleans using
field notes, medication diaries, and pill count and found a significant association between
illness perception and treatment adherence behaviors (p = .01 and .001). Participants
who perceived the cause of hypertension within the non-biomedical model were more
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likely to be non-adherent with their medications compared to those who had biomedical
views of hypertension (relative risk = 2.3; 95% CI [1.2-4.4]). Heckler et al. (2008)
carried out the most recent study on the impact of perception or common-sense illness
beliefs on therapy adherence among 102 Black adult hypertensive patients. This study
found that perception of stress as the cause of hypertension correlated (r = .34, df = 100,
p < .01) with engaging in stress-reducing behaviors to manage high blood pressure at the
expense of medication and lifestyle modifications, while beliefs in the biomedical model
of hypertension weakly correlated with medication adherence and lifestyle modifications
to control high blood pressure (r = - .21, df = 100, p < .05).
Some intervention studies, with sample sizes ranging from 55 to 1,059, did not
directly target hypertension perceptions but instead aimed at improving understanding of
hypertension, medication adherence, and blood pressure control or reduction among
Black hypertensive adults; these studies have reported mostly non-significant differences
in blood pressure control or reduction between the intervention and control groups from
baseline to follow-up (Greer et al., 2015; Ogedegbe et al., 2008; Johnson et al., 2011;
Roberts et al., 2012; Ogedegbe et al., 2014; Webb, 1980).
There is an obvious gap in knowledge: Though qualitative studies have elicited
various levels of misconceptions about hypertension among Black adults, there have not
been many quantitative studies exploring the relationship between these misconceptions
about hypertension and medication adherence. Most of what is known about
hypertension perception among Black adults has been based on qualitative studies with
samples that were majority female. As discussed earlier, the most recent study that
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explored the association between hypertension perception and medication adherence
among Black hypertensive adults was in 2008.
To address this gap in knowledge, the central aim of the present study is to
examine the association between hypertension perceptions and medication adherence
among Black hypertensive adults 35 to 65 years old being treated for hypertension in
primary care settings and to examine whether there will be any gender differences in
hypertension perceptions and medication adherence.
Innovation. The present study of the association between hypertension
perceptions and medication adherence is the first to focus specifically on Black
hypertensive adults 35 to 65 years old in primary care. Recruiting participants from
multiple primary care clinics will produce a sample that is not only heterogeneous, but
also representative of the population of interest. The findings of the present study will
help expand the knowledge-base about the association between hypertension perceptions
and medication adherence among this population. Most of what is currently known about
hypertension perceptions among Black hypertensive adults have been based solely on
qualitative studies. This study will be one of the few studies that examine the association
between hypertension perceptions and medication adherence, where hypertension
perceptions will be measured quantitatively, allowing for analysis of the relationship
between these two variables. The validity of the findings of this study will be enhanced
by controlling for most of the important confounding factors known to impact medication
adherence and illness perceptions. The present study will also highlight whether there are
gender differences in hypertension perceptions and medication adherence. Most of what
is known about hypertension perception or its association with medication adherence
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among Black adults has been based on studies with samples that were majority female,
however, the present study will attempt to recruit a good representation of both genders.

Approach
Research design and setting. This is an observational cross-sectional research
design study. A non-probability sampling method will be used in recruiting participants
into the study. Potential participants will be recruited concurrently from four primary
care clinics in the Houston TX metropolitan area. One clinic is an employee-based
primary care clinic, while the other three are internal medicine or family primary care
clinics that serve large populations of Black hypertensive adult patients. Recruitment
from the clinics will occur in person as the patients present for their regularly scheduled
appointments with their healthcare providers. Participants’ voluntary participation will be
sought by the principal investigator (PI) in the waiting area or lobby of the clinics.
Additionally, recruitment flyer will be placed in the lobby and examination rooms of the
clinics so that potential participants whose doctors’ visits occur when the PI is not present
in the clinic will have the opportunity to contact the PI if interested in study participation.
The rationale for recruiting from several clinics is two-fold: to recruit a sample
that will be representative of the intended patient population and to counteract the chance
for low response rate that could occur if recruitment is limited to only one or two sites.
Studies have suggested that Blacks tend to be hesitant with participating in research
studies due to mistrust for the healthcare system (Scharff et al., 2010; Kennedy, Mathis,
& Wood, 2007). In addition to recruiting from multiple sites, other strategies to improve
participation include offering compensation; ensuring convenience by completing the
questionnaires at the time of already scheduled doctors’ appointments; using direct face-

17
to-face interaction since in-person reassurance increases comfort with the research
process (Satia, Galanko, & Rimer, 2005); and offering tangible incentives (Qualls, 2002).
Each participant will receive a $15 gift card to Wal-Mart or Starbucks in appreciation for
their time and effort, which should in turn improve response rate. Gift card incentives
were found to be one of the predictors of increased survey response rate among African
Americans (Liu, & Geidenberger, 2011). Lukoschek (2003) and Heckler (2008)
compensated their respective sample of hypertensive Black adults in an amount ranging
from $10 to $15.
Approval to conduct the study will be obtained from the University of Texas
Health Science Center-Houston Institutional Review Board (IRB). Written permission to
recruit patients and conduct chart review will be obtained from each of the clinics’
management. Consent will be obtained from each participant for participation and chart
review. Recruitment is anticipated to last up to three months. Validated instruments will
be used to collect data on the dependent variable (medication adherence) and independent
variables (illness perceptions), while a short form will be designed to collect
demographic data and information about potential confounders. The purpose of the chart
review is to verify information about demographic characteristics, confounders, and
eligibility criteria.
Sample selection criteria. The sample selection criteria are as follows:
Inclusion Criteria. (a) Self-identified Black adults; (b) males and females, aged
35 to 65 years; (c) diagnosis of primary/essential hypertension (PI will confirm during
chart review); (d) duration of hypertension diagnosis for at least 12 months (PI will
confirm during chart review); (e) have been prescribed or is taking at least one
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hypertensive medication (PI will confirm during chart review); (e) participants must be
able to read and write in English.
Exclusion criteria. (a) Potential secondary hypertension as supported by history
of sleep apnea, renal artery disease, stenosis, certain cardiovascular diseases,
hyperthyroidism, pregnancy, or adrenal gland tumor (pheochromocytoma) upon chart
review by PI, (b) severe mental disorder that can hinder comprehension of instructions;
(c) refusal to provide informed consent.
Sample size estimation. The estimated sample size was based on multiple
regression since both the dependent and independent variables are continuous. Sample
size was estimated through power analysis using G*Power (Faul, Erdfelder, Lang, &
Buchner, 2007). With an alpha level of .05, power of .80, small effect size of .07 (F2),
and number of predictors as 10 (seven IR subscales plus theorized potential three
subscales of the Cause section), the estimated sample size is 115. Even though the
estimated sample size is 115, the PI plans to recruit up to 150 respondents to compensate
for missing data and to have a reasonable sample size for factor analysis as planned in
this study.
No software was identified that can be used to determine sample size for factor
analysis. The developers of the IPQ-R questionnaire have recommended that factor
analysis can be conducted using a sample size of 85 or more (Moss-Morris et al., 2003).
However, some authors have recommended that a sample size of 150, or 10 cases per
item to be analyzed, while others recommend a ratio of 5 cases per item (Pallant, 2007).
A study that explored the association between illness perception and self-care behavior
among Black hypertensive adults, 18 to 65 years, conducted a factor analysis of the 18
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causal items of the IPQ-R using a sample of 111, so the present study will use any sample
size close to 111 in conducting a factor analysis.
To reach the indicated sample size, the PI estimates that about 500 potential
participants may need to be approached and screened. This is only an estimate since the
PI will have no prior knowledge of how many patients in the clinic will meet inclusion
criteria in this study considering that there will be no chart or record review before data
collection. Additionally, most of the clinics are not able to run an accurate report on their
patient population to identify the number of patients that are likely to meet inclusion
criteria. However, to maximize the chance to recruit a meaningful number of participants
on each recruitment day, the PI will ask the clinics to indicate which days and times
many patients that are likely to meet inclusion criteria are scheduled, and the PI will be at
the clinics on those days.
Instruments.
Illness Perception Questionnaire. Illness (hypertension) perception will be
measured using the revised Illness Perception Questionnaire (IPQ-R), a scale that was
developed to quantitatively assess patients’ perception of illnesses across a range of
chronic diseases (Moss-Morris et al., 2002). The questionnaire was developed using the
constructs of the common-sense model as the theoretical framework. The IPQ-R consists
of two illness perception components, namely Illness Representation (IR) and Causes.
The Identity component was not part of the revised IPQ-R, though it was only included
for the purposes of psychometric testing (Moss-Morris et al., 2002). This study will
survey participants using the hypertension version of this scale.
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The IR component of the IPQ-R consists of 38 questions incorporated into seven
subscales: Timeline (acute/chronic), Cyclical Timeline (episodic/temporary/
unpredictable), Treatment Control, Personal Control, Consequences, Illness Coherence,
and Emotional Representations. Timeline (acute/chronic), Consequences, Personal
Control, and Emotional Representations are represented by six items on the
questionnaire, respectively, while five items represent Treatment Control and Illness
Coherence, respectively. Finally, Cyclical Timeline is represented by four items on the
questionnaire. Each item is ranked on a Likert-type scale, with responses ranging from 1
(strongly disagree) and 5 (strongly agree). High scores on the respective subscales
supports beliefs that hypertension is a chronic illness (Timeline), unpredictable/episodic
(Cyclical Timeline), can severely impact quality of life (Consequences), and that it can be
controlled by either personal behaviors (Personal Control) or by medical treatment
(Treatment Control) (Moss-Morris et al., 2002). The coherence subscale represents good
personal understanding of the condition; thus, having a high score on a statement such as,
“I have a clear picture or understanding of my high blood pressure,” indicates a good
understanding of hypertension. The score from each subscale is summed to get a total for
the respective subscales. There is no overall total score for the IPQ-R.
The Cause component of the IPQ-R contains an additional 18 short items, which
the developers recommend using as a grouping variable through factor analysis when
there is sufficient sample size (85 or more) to identify the respective dimensions of
perceptions of cause of an illness, after which the groups can be used as subscales in the
analysis (Moss-Morris et al., 2002).
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The authors of the IPQ-R tested its validity using principal component analysis
(PCA), where seven IR subscales were extracted, each with at least three factor loadings
ranging from 0.5 to 0.86 (Moss-Morris et al., 2002). The Cronbach’s alpha ranged from
.79 to .89 for the IR subscales, and .67 to .86 for the causal items (Moss-Morris et al.,
2002). Validity evidence was further explored by a study that aimed to examine the
association between hypertension perception and self-care behavior among 111 Black
hypertensive adults, 18 to 65 years, and reported Cronbach’s alphas ranging from .59 to
.83 for the seven IR subscales, where Treatment Control had the lowest internal
consistency (Cronbach’s alpha .59), followed by Personal Control (.63) and
Consequences (.66) (Picket et al., 2014).
The authors of the scale extracted three subscales from the 18 causal attribution
items; which include (a) psychological factors, such as stress, and emotions; (b) risk
factors, such as heredity, aging, poor medical care, and health behaviors; and (c)
immunity, such as pollution, virus or altered immunity. These three causal subscales had
Cronbach’s alphas ranging from .67 to .86. Additionally, the study by Picket et al.
(2014), which used a sample of 111 African Americans, also extracted three causal
attribution subscales with acceptable factor loadings, including (a) psychological factors
(emotional state, mental attitude, personality, family problems, overwork, or aging); (b)
uncontrollable factors, such as germs or viruses, pollution, chance or bad luck, altered
immunity, or accidents; (c) biomedical explanation, such as personal behavior, diet or
eating habit, stress or worry, or poor medical care. The dimensions of causal attribution
from the factor analysis conducted by these respective authors were similar and
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consistent with each other except for one item (“stress or worry”), which seemed to
overlap between psychological and biomedical dimensions.
The planned factor analysis in the present study would likely extracted similar
dimensions. Though the causal attribution subscales by Moss-Morris et al. (2002)
demonstrated acceptable reliability with Cronbach’s alpha coefficients ranging from .67
to .86, the sample was general population with respective medical illnesses. However,
Pickett et al (2014) used a sample of Black hypertensive adults and identified three
meaningful causal subscales, but no reliability testing of these subscales was conducted.
In the present study the PI will test the internal consistency reliability of the IR
subscales and the causal attribution subscales. For each subscale a Cronbach’s alpha
coefficient of at least 0.70 will be considered acceptable evidence of reliability.
However, subscales that have a Cronbach’s alpha less than .7, but not below .6, will be
included in the final analysis, but the low internal consistency will be discussed as a
weakness or limitation to the study’s finding as it relates to that particular subscale. Any
subscale with a reliability coefficient less than .6 will be eliminated, and the final analysis
will be conducted without that subscale.
Hill-Bone Blood Pressure Therapy Compliance Scale. The dependent variable
“medication adherence” will be measured using the Hill-Bone Compliance to High Blood
Pressure Therapy Scale. The questionnaire was designed to assess patient behaviors for
three behavioral domains of high blood pressure therapy, including reduced sodium
intake, appointment keeping, and medication adherence (Kim, Hill, Bone, & Levine,
2000), however, only the medication subscale will be used in this study since the focus is
on medication adherence. The total scale contains 14 items, grouped into three subscales,
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of which eight items were related to questions about medication adherence; one
prescription-filling adherence question is often used by researchers in addition to the
eight medication-taking items. The authors indicated that researchers interested in
measuring medication adherence should use the medication-taking subscale alone. Each
item on the scale is a four-point Likert type scale (“4” equals “all the time” and “1”
equals “none of the time”). The lower the scores, the better the patient’s adherence level.
According to the authors, the items are assumed to be additive; thus, when summed, a
score of nine on the medication adherence subscale represents “perfect adherence” while
a score of 36 denotes “perfect non-adherence.”
Validity of the questionnaire was established through two studies: one that
utilized 309 hypertensive Black males 18 to 55 years old and another with 718 Black
hypertensive adults 18 years and older; these studies’ Cronbach’s alpha coefficients were
.74 and .85 for the total scale, respectively (Kim et al., 2000). In addition, a study with a
sample of 80 Black women assessing the relationship between spirituality and medication
adherence reported a Cronbach’s alpha of .843 for the medication adherence subscale
(Abel & Greer, 2017). A study with a sample of 190 urban Black men reported a
Crobanch’s alpha of .77 for the medication adherence subscale of the questionnaire (Kim,
Han, Hill, Rose, & Roary, 2003). Eight experts confirmed the content validity of the
scale; additionally, construct validity through PCA using varimax rotation extracted three
subscales, though factor loading in both study 1 and 2 showed that the medicationadherence subscale possessed the most meaningful loadings. Predictive validity showed
that the summed scores of each subscale correlated with blood pressure level and control
(Kim et al., 2000).
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Demographic data and confounding variables form. A short questionnaire will
be designed to collect demographic data including age, gender, health insurance, and
employment status. The demographic data form will also be used to collect data about
covariate or confounding variables anticipated to impact both illness perceptions and
medication adherence, including duration of hypertension diagnosis, educational level,
experience of hypertension-related symptoms, severity of hypertension, and history of
depression (comorbidity) diagnosed by a healthcare provider. Educational level will be
operationally categorized into four levels: “less than high school,” “high school,” “some
college or trade school,” and “four-year college or greater.” Gender will be categorized
into two options, “male” or “female.” Participants will be asked to state how long they
have been diagnosed with hypertension. Severity of hypertension will be categorized
into two levels based on blood pressure classification by the Joint National Committee on
Prevention, Detection, Evaluation and Treatment of Hypertension ([JNC], 2003): stage 1
= 140-159/90-99; stage 2 = ≥160/≥100, where stage 1 will represent mild hypertension,
and stage 2 will represent severe hypertension. The average of the past two blood
pressure readings will be taken to decide on the severity of blood pressure. Symptoms of
hypertension will be categorized as “yes (present)” or “no (absent).” In addition, chart
review will be conducted to verify information about demographic characteristics and
confounders.
Procedures for data collection. Questionnaires that will be completed include
the 56-item Illness Perception Questionnaire, the nine-item Hill-Bone medication
adherence questionnaire, and a short (10 items) demographic questionnaire, for a total of
75 items.
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Data collection from the four clinics will occur in person, where the principal
investigator (PI) will recruit participants as they come to their regularly scheduled
appointments with their healthcare providers. Every adult patient of African ancestral
origin waiting to see their healthcare providers in the lobby or waiting area of the clinics
to see their healthcare providers, will be approached by the PI with the recruitment flyer.
Those who indicate interest, meet inclusion criteria, and give informed consent, will be
given the questionnaires to complete. Each completed questionnaire will be assigned a
study identification number.
In addition, recruitment flyers will be placed in the clinics’ lobbies or waiting
areas as well as exam rooms, so that patients whose doctors’ appointments occur when
the PI is not present at the clinics can still contact the PI for participation if interested.
The recruitment flyer will contain information about the purpose of the study, inclusion
criteria, and procedure, as well as the PI’s contact information. The consent form will
contain the purpose of the study, benefit, risks, and confidentiality, as well as the PI’s
contact information.
Any participant who contacts the PI over the phone and indicates interest in
participation, will be scheduled to meet with the PI at the clinic during their next
scheduled appointment at the clinic for completion of the questionnaires and consent
forms. Understandably, there may be a chance that it may not be feasible for the PI to
meet with these patients since their next appointment could be in another three months.
Even though patients with chronic illnesses such as hypertension are usually seen by their
healthcare providers every three to six months, the frequency of visits is often determined
by whether patients’ hypertension is controlled versus uncontrolled, and by other medical
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needs of the patient. These potential participants may have additional visits to the clinics
for other medical needs since these are their medical homes.
Privacy will be maintained while interacting with the potential participants in the
lobby, and neither the PI nor the participants will engage in any discussion pertaining to a
sensitive or private issue in the lobby. Each participant will receive a Walmart or
Starbucks gift card worth $15 at the completion of the questionnaires.
Chart review will be conducted to confirm diagnosis of primary or essential
hypertension, duration of hypertension diagnosis, history of depression, and blood pressure
reading after the participants have signed consent forms and completed the questionnaires.
To conduct chart review, each participant will be asked for their name and date of birth,
which will be written on a separate paper with the respondents’ study identification
numbers. This information will only be needed to identify the respective charts for review
on the day the questionnaires are completed and will be shredded before the PI leaves the
clinic. After chart review, the participants’ completed questionnaires will only retain the
respective study identification numbers, and no other form of identifier will be attached to
the completed questionnaires. During chart review, the electronic medical record (EMR)
for the clinics that are using EMR usually will record patients’ hypertension diagnosis as
primary/essential or secondary. When not sure, merely clicking on the diagnosis
(hypertension) from the list of patients’ diagnoses will reveal the ICD-10 (I10) code for
essential/primary hypertension. For clinics using paper charts, in the absence of other
disease that could cause elevated blood pressure, the handwritten diagnosis of
“Hypertension” or “HTN” in the chart by the providers will be assumed to refer to
primary/essential hypertension.
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Data analysis. All data analysis will be conducted using SPSS software, version
23. Descriptive statistics will be conducted to explore characteristics of the sample.
Respective descriptive statistics will be conducted to explore distributions for the
continuous independent variables as well as the frequency of the categorical outcome
variables. In addition, a univariable analysis will be conducted to check for association
between medication adherence and each of the predictor (illness perceptions) variables.
Reliability testing will be conducted to check for the reliability of the IPQ-R subscales
(IR and Cause subscales) for the current sample. Factor analysis of the causal items will
be conducted first to identify the causal attribution subscales; then these subscales will be
used in combination with other IPQ-R (IR) subscales to conduct the multiple regression
for Aim #2. Multiple regression will be conducted to check whether all or some the IPQR subscales predict medication adherence while controlling for covariates.
Aims, hypotheses, and statistical testing.
Aim #1: To explore participants’ perceptions about the cause of hypertension.
Hypothesis #1: Among other factors, perception of psychological factors as cause of
hypertension will explain the highest variance in views about the cause of hypertension.
Statistical Analysis for Aim #1: Factor analysis will be conducted using the 18 cause
perception items of the IPQ-R. Exploratory factor analysis with varimax rotation will be
conducted to decipher the cluster of views about the cause of the sample’s hypertension.
Factors with acceptable factor loadings will be selected and defined. The decision to
assign an item to a factor will based on a priori setting of greater than or equal to .40 for
factor loadings and less than or equal to .20 for cross-loadings (Ferguson & Cox, 1993).
An acceptable loading for each factor must be at least three items (Watson & Thompson,
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2006). Previous studies have identified three meaningful causal attribution factors using
the IPQ-R scale (Moss-Morris et al., 2003; Pickett et al., 2014).
Aim #2: To examine the relationship between medication adherence and perceptions
about hypertension timeline, controllability, consequences, emotional representation,
illness coherence, and cause among Black hypertensive adults 35 to 65 years old, while
controlling for depression, educational level, age, duration of hypertension diagnosis,
experience of hypertension-related symptom, and severity of hypertension.
Hypothesis #2: There will be a statistically significant positive relationship between
medication adherence and hypertension perceptions, where high scores on the subscales
of the IPQ-R will be associated with better medication adherence scores.
Statistical Analysis for Aim#2: Multiple regression analysis will be conducted to
determine whether IPQ-R subscales (Timeline [acute/chronic], Cyclical Timeline
[episodic], Personal Control, Treatment Control, Consequences, Emotional
Representation, Illness Coherence, and Cause) will predict medication adherence while
controlling for the confounders (hypertension-related symptoms, severity of
hypertension, depression, age, educational level, and duration of hypertension diagnosis).
All potential confounding variables will be included in the initial model, and
nonsignificant ones will be eliminated one at a time, starting with the highest p-value.
Only significant confounders (p < .05) will be retained.
Aim #3: To explore to what extent hypertension perceptions and medication adherence
differ by gender while controlling for confounders.
Statistical Analysis for Aim #3(a): Since illness perception is continuous variable while
gender is a categorical variable, ANCOVA will be the most appropriate analysis to
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explore gender differences in each of the hypertension perceptions subscales.
Confounders that will be controlled for include educational level, age, and duration of
hypertension diagnosis.
Statistical Analysis for Aim #3(b): A second ANCOVA will be conducted to explore to
what extent medication adherence differs by gender after controlling for age, number of
medications, educational level, and comorbidity (depression).
Limitations. Misclassification of medication adherence or illness perceptions
may be one of the limitations of this study due to the use of self-report questionnaires to
measure these variables. Self-report questionnaires may lead to participants’
overestimation of adherence, recall bias, and likelihood for giving socially acceptable
responses (Morisky et al., 2008). Additionally, data collection will involve use of long
self-report questionnaires, which may lead to a high rate of missing data, however, the
sentences are short, easy to understand, and the questionnaire takes less than 20 minutes
to complete. The PI will review the completed questionnaires at time of completion, and
each participant will be asked to complete any missing data.
Another limitation of this study is that cause and effect cannot be established with
cross-sectional study designs. Conducting factor analysis with a small sample size may
also cause the factor structures to be unreliable (Pallant, 2007). One major problem with
the proposed procedures is the inability to recruit the estimated sample size; however, the
chance for this problem is reduced since recruitment will occur in several clinics.
Despite these limitations, there is value in the knowledge to be gained and the results will
inform future longitudinal studies with larger sample sizes.
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Another important limitation is the inability to address the impact of acculturation
on hypertension perceptions, specifically in terms of the duration a foreign-born
participant may have lived in the US. However, the current study’s focus is not strictly
on a foreign-born sample of hypertensive population. Future study in this area could
focus on exploring the association between hypertension perceptions and acculturation
among foreign-born hypertensive Black adults residing in the US.

Human Subjects
Approval to conduct this study will be obtained from the University of Texas
Health Science Center - Houston Institutional Review Board (IRB). Health Insurance
Portability and Accountability Act (HIPPA) guidelines will be maintained throughout the
process. Consent will be obtained from participants for participation and chart review.
Permission for recruitment will be obtained from each recruitment sites. All signed
consent forms will be separated from the completed questionnaires and stored in a
different folder in a locked cabinet. The PI will not leave the clinics with any patientidentifying data from participants’ charts. No date of birth or name will be recorded on
the completed questionnaires; however, the PI will collect participants’ names and date of
birth for chart review; in addition, the HIPPA consent forms will also contain the
participants’ names and signature. Any identifier collected from the participants to
identify their records for chart review will be shredded in the clinic before the PI departs
on each recruitment day. In general, there is minimal risk involved in this study. This
study is not anticipated to infringe on participants’ rights or cause any harm.
One of the risks that could be associated with this study is breach of
confidentiality. To ensure confidentiality, a study identification number will be assigned
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to each participant, and data from completed questionnaires will not be linked to with any
personal identifiers. Confidentiality will be strictly protected to the extent allowable by
law. The principal investigator, dissertation chair, and statistician will have access to
questionnaire data or survey responses, and these data will be completely de-identified;
thus, participation in the study will not affect participants’ care at the clinics.
No patient-identifying information will be included in any publication of the
study. Questionnaires and consent forms will be stored in separate folders in a locked
cabinet and will be shredded one year after the study is completed.
Another risk is the discomfort that may originate from having to complete several
questionnaires with a total of 75 items, however, the sentences are short and easy to
understand. Participants will be assured they can take a break or stop the questionnaire at
any time if they experience any physical discomfort or fatigue while completing the
questionnaires.
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Introduction
Hypertension (HTN) is the leading cause of most cardiovascular diseases
(Valderrama, Gillespie & Mercado, 2013). Among non-Hispanic Blacks aged 20 years
and older, 45% of males and 46.3% of females have hypertension, compared to 34.5% for
White males and 32.3% for White females (American Heart Association [AHA], 2017a).
Uncontrolled hypertension is considered an important risk factor for coronary heart
disease, stroke, congestive heart failure, end-stage renal disease, and peripheral vascular
disease (AHA, 2017b; Sulainman et al., 2009). Compared with Whites, Blacks develop
hypertension at an earlier age, have higher average blood pressure, and poorer blood
pressure control, leading to Blacks with hypertension having 1.3 times greater rate of
nonfatal stroke, 1.8 times greater rate of fatal stroke, 1.5 times greater rate of heart
disease death, 4.2 times greater rate of end-stage kidney disease, and 50% higher
frequency of heart failure (AHA, 2015; Go et al., 2014).
Although 80.8% of Blacks are aware of their hypertension, with 71.9% under
treatment, only 36.9 % have their hypertension under control; meanwhile, 79.1% of
Whites are aware of their hypertension, with 73.9% under treatment, and 42.9% have
controlled hypertension (AHA, 2017c; Valderrama & Gillespie, 2013). Black adults are
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more likely to be non-adherent to antihypertensive medications and more likely to have
uncontrolled hypertension than other races (Redmond, Baer, & Hicks, 2011; Dickinson &
Plauschinat, 2008; Bosworth et al., 2006). Shaya et al. (2009) examined predictors of
antihypertensive therapy adherence among 568 Medicaid hypertensive patients and found
that Blacks were 50% less adherent to medication compared to their White counterparts.
Furthermore, a longitudinal cohort study among hypertensive Medicaid recipients found
that African American patients were less adherent to medications than Whites (55% vs.
61%, p < .05) (Dickson & Plauschinat, 2008). Non-Hispanic Blacks had 90% higher
odds of poorly controlled hypertension compared to non-Hispanic Whites, even after
controlling for socioeconomic status, gender, age, and other clinical factors, such as
smoking status, sodium intake, and alcohol (Redmond, Baer & Hicks, 2011).
Even with the advancement over the years in treatment options for hypertension
and other cardiovascular disease risk factors, uncontrolled hypertension remains a public
health burden in the United States (Mozaffana et al., 2015; Chobanian, 2015).
Furthermore, Chobanian (2015) asserts that evidence has shown that the new and
advanced antihypertensive medication options have been shown to be effective in
controlling hypertension in anyone, irrespective of race.
Better understanding of the critical factors impeding medication adherence and
blood pressure control among Black hypertensive adults will inform the design and
implementation of meaningful interventions to curtail the alarming burden of
uncontrolled hypertension among the Black adult population. Factors affecting
medication adherence among Black hypertensive adults seem to be multifaceted. A
systematic review by Lewis (2012) explored several factors theorized by researchers to
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impact medication adherence among Blacks, including healthcare system, nature of
hypertension as an often-non-symptomatic disease, treatment complexity, presence of
other comorbidities, and patient-related issues.
Many qualitative studies have reported that Black adults have misconceptions
about hypertension (Ogedegbe, Mancuso, & Allegrante, 2004; Lukoschek, 2003; Wilson
et al., 2002), but only a few studies have examined the relationship between these
misconceptions and medication adherence (Heckler et al., 2008; Heurtin-Roberts &
Resisin, 1990). There is a need to have a better understanding of perceptions about
hypertension held by Black hypertensive adults and the extent to which these perceptions
impact medication adherence. The current study focuses on Black hypertensive adults
aged 35 to 65 years because this is the age group that has a high incidence and prevalence
of hypertension among Black adults. Although individuals start developing hypertension
around middle age, Blacks develop hypertension at an even younger age on average
(CDC, 2016; AHA, 2016).
The first objective of this study was to investigate perceptions of causal
attributions of hypertension among Black hypertensive adults. The second but primary
objective of the current study was to examine whether there is an association between
hypertension perceptions and medication adherence among Black hypertensive adults 35
to 65 years of age in primary care settings, after controlling for the effects of certain
confounders that could also impact hypertension perceptions and medication adherence.
Because most of the existing knowledge about hypertension perceptions among Black
adults is based on studies with majority-female samples, the third objective was to
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explore whether there were gender differences in hypertension perceptions and
medication adherence.

Background
The World Health Organization ([WHO], 2003) defines medication adherence as
the extent to which a patient’s medication-taking behavior matches with agreed
recommendations from a healthcare provider. Medication adherence is further defined as
the degree to which a patient follows recommended advice or takes medications with the
timing, dosing, and frequency prescribed by their healthcare providers (Cramer et al.,
2008). According to the WHO (2003), the patient should be considered an active
collaborator in their treatment rather than a passive recipient of advice from healthcare
providers.
The poor medication adherence and hypertension control among Black
hypertensive adults have placed a high burden of morbidity and mortality associated with
hypertension on this population as well as posed a serious public health burden. A 30year mortality risk among White hypertensive men was 23.8%, compared to 45.2% for
Black hypertensive men, and 18.3% for White women, compared to 39.5% for Black
women (Lackland, 2014). According to the Agency for Healthcare Research and Quality
([AHRQ], 2013), in 2010, direct medical expenditure for hypertension totaled 42.9
billion, with a higher percentage of non-Hispanic Blacks (30.4%) being treated for
hypertension than non-Hispanic Whites (26.7%); furthermore, annual expenditure for
those treated for hypertension averaged $733 per adult, while mean expenditure per
person with hypertension was $887 for Blacks compared to $679 per person for nonHispanic Whites. The AHA projects the cost of medical care for hypertension will
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increase from $69.9 billion in 2010 to $200.3 billion in 2030 (Heidenreich, 2011), while
the Center for Disease Control and Prevention ([CDC], 2016) reports that hypertension
costs $48.6 billion yearly.
As noted earlier, the reason for medication non-adherence and poor blood
pressure control among Blacks seems complex and multifaceted. Individual studies have
outlined factors such as poor socioeconomic status, distrust for physicians, racial
discrimination, comorbidities, disease-related problems (such as absence or presence of
symptoms), complexity of medication regimen, patient-provider communication,
depression, and a fatalistic view of hypertension (Greer, 2010; Ndumele et al., 2010;
Ogedegbe et al., 2003; Ogedegbe et al., 2004). Additionally, a recent study with a
majority-Black-hypertensive-adult sample noted that patient-provider interaction that
does not involve the patient or involve patients’ sociodemographic needs often leads to
poor medication adherence (Schoenthaler, Knafl, Fiscella, & Ogedegbe, 2017). The
systematic review by Lewis (2012) on factors affecting medication adherence among
Black hypertensive adults reported that non-adherence was consistently associated with
self-efficacy; depression; patient-provider communication and system-related factors;
disease-related factors, such as presence or absence of symptoms; and severity of
hypertension.
Although the poor medication adherence and blood pressure control among Black
hypertensive adults have been attributed to numerous factors, the solution to the problem
remains difficult and elusive (Kressin, Orner, Manze, Glickman, & Berlowitz, 2010).
Most of the existing interventions to address some of these factors have only yielded

47
inconclusive or non-promising results; thus, the need to explore other potential
contributing factors, such as illness perception.
Illness perception is conceptually defined as an individual’s beliefs or cognitive
understanding about an illness (Leventhal et al., 2003). A deeper understanding of illness
perception has been shown to be useful in assessing patients’ illness outcomes (Figueiras
& Alves, 2007; Hagger & Orbell, 2003). When faced by a health threat, an individual
cognitively evaluates and tries to make sense of the health threat, after which the
individual is likely to develop a coping mechanism that is guided by the level of risk
perceived about the illness. These beliefs can be shaped by medical knowledge through
interaction with healthcare providers, personal experiences, and/or experiences of others,
such as family or friends (Petrie & Weinman, 2006). An individual who holds a
misguided perception or understanding about the cause, complications, timeline,
controllability/cure, and chronicity of hypertension is likely to be non-adherent to
prescribed medications.
Middleton (2009) suggested that the lower rates of adherence to prescribed
therapy for hypertension, including exercise, diet, and medication among Black
hypertensive adults may be related to the inaccurate illness perceptions held about
hypertension that are not consistent with a biomedical disease model of hypertension.
Ross et al. (2004) discussed the effect of illness beliefs on predicting medication
adherence, and further reported that patients who do not perceive hypertension to be
serious may self-regulate their antihypertensive medications accordingly. The authors
further suggested that targeting patients’ health beliefs may be important in designing
interventions to improve adherence to antihypertensive therapy. A qualitative study with
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a sample of 19 African-American, 20 White, and nine Hispanic Veterans Administration
patients, reported that among other factors, patients’ perceptions of the cause, course of
hypertension, and experiences of hypertension symptoms were linked with their reports
of their self-management behaviors (Bokhour et al., 2012). A quantitative study by
Rajpura and Nayak (2014), with a sample that was made up of 76.9% Whites and 18.8%
Blacks aged 55 years and older reported that more favorable perceptions of illness were
associated with higher medication adherence scores (p = .001).
Conceptual framework. The self-regulation of health and illness model, also
known as the common-sense model (Leventhal, Brissette, & Leventhal, 2003) served as
the theoretical guiding framework for the present study. This model emphasizes the role
of illness perception in guiding coping behaviors toward an illness, which subsequently
affect illness outcomes. The model proposes that in response to a health threat,
individuals may develop both parallel cognitive and emotional representations, which in
turn gives rise to problem-based and emotional-focused coping behaviors (Leventhal et
al., 2001). The authors proposed that response to illness involves three processes, namely
representation, coping, and appraisal.
The model posits that the mental impressions patients attach to the identity
(symptoms), duration of illness, illness outcome/consequences, causal factors, and
control/curability guide their coping mechanism toward the illness. When faced with a
health threat, the individual tries to develop a cognitively-reasoned understanding of the
health threat, eventually develops a coping mechanism based on personal mental
representation of the illness, and, finally, with time, appraises such coping mechanisms.
In this study, the coping behavior of interest is medication adherence. If an individual
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wrongly perceives an illness such as hypertension to be non-life threatening or a disease
without consequences (complications), adherence to medication may be low.
The model identifies five constructs of illness representation as follows (Leventhal et
al., 2003), namely: (a) Identity/Label (Symptoms); (b) Timeline; (c) Consequences; (d)
Cause; and (e) Control/Cure. Identity represents the label a patient assigns to personal
symptoms or perception of symptoms associated with the illness. Timeline represents the
patient’s perception of the duration of the illness in terms of whether the illness is
acute/temporary, chronic, or cyclical in nature. Consequence signifies the level of threat
or complications perceived to be associated with the illness. Cause represents perceived
etiology of the illness as it relates to external or internal factors or stressors. Finally,
Control or Cure represents what the individual thinks about the controllability or
curability of the illness by medication, and/or whether they can do what is needed to
control the disease.
Most patients with high blood pressure often misconceive the disease as a non-lifethreatening illness, especially due to its mostly asymptomatic nature. A misguided view
of hypertension may lead to non-adherence behavior with prescribed medication. This is
particularly important among Black adults as studies have reported that most Blacks
attribute the cause of hypertension to stress or other psychologically-based factors and
often engage in stress-management activities to control hypertension at the expense of
medications (Heckler et al., 2008; Heurtin-Roberts, 1990; Rose, Kim, Dennison, & Hill,
2000; Wilson et al., 2002).
The asymptomatic nature of hypertension has led some patients to question their
diagnosis of hypertension and the need for treatment for the disease (Schlomann, &
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Schmitke, 2007). Some patients with hypertension often adjust their medication based on
symptoms, which may be very deceiving since lack of symptoms does not necessarily
indicate the absence of elevated blood pressure or hypertension (Schlomann, & Schmitke,
2007); thus hypertension is called a silent killer.
The literature search revealed that only a few studies have examined the
relationship between perceptions of hypertension and medication adherence among Black
hypertensive adults. An older study by Heurtin-Roberts and Reisin (1992) assessed the
relationship between lay beliefs about hypertension and medication adherence among 60
Black hypertensive women attending a public-hospital-based clinic in New Orleans using
field notes, medication diaries, and pill count. Participants who perceived the cause of
hypertension within the non-biomedical model were more likely to be non-adherent with
their medications compared to those who had biomedical views of hypertension (relative
risk = 2.3; 95% CI [1.2-4.4]). Heckler et al. (2008) carried out the most recent study on
the impact of perception or common-sense illness beliefs on therapy adherence among
102 Black adult hypertensive patients. This study found that perception of stress as the
cause of hypertension correlated (r = .34, df = 100, p < .01) with engaging in stressreducing behaviors to manage high blood pressure at the expense of medication and
lifestyle modifications, while beliefs in the biomedical model of hypertension weakly
correlated with medication adherence and lifestyle modifications to control high blood
pressure (r = - .21, df = 100, p < .05).
Some intervention studies with sample sizes ranging from 55 to 1,059, did not
directly target hypertension perceptions, instead aiming at improving understanding of
hypertension, medication adherence, and blood pressure control or reduction among
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Black hypertensive adults; these studies have reported mostly non-significant differences
in blood pressure control or reduction between the intervention and control groups from
baseline to follow-up (Greer et al., 2015; Ogedegbe et al., 2008; Johnson et al., 2011;
Roberts et al., 2012; Ogedegbe et al., 2014; Webb, 1980).
There is an obvious gap in knowledge; though qualitative studies have elicited
various levels of misconception about hypertension among Black adults, there are very
few quantitative studies investigating the relationship between perceptions about
hypertension and medication adherence. As discussed earlier, the most recent study that
explored the association between hypertension perception and medication adherence
among Black hypertensive adults was in 2008.
To address this gap in knowledge, the central aim of the present study was to
investigate whether there is an association between hypertension perceptions and
medication adherence among Black hypertensive adults 35 to 65 years old being treated
for hypertension in primary care settings. Specifically, the purposes of this study were to:
1. Investigate participants’ perceptions about causes of hypertension. It was
hypothesized that, compared to other factors, perceptions of psychological factors
as the cause of hypertension will explain the highest variance in views about the
cause of hypertension.
2. Examine the relationship between medication adherence and hypertension
perceptions as related to views about hypertension timeline, controllability,
consequences, emotional representation, illness coherence, and cause while
controlling for depression, educational level, duration of diagnosis, hypertensionrelated symptoms, and severity of hypertension. It was hypothesized that there
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will be a statistically significant relationship between perceptions of hypertension
and medication adherence.
3. Explore to what extent hypertension perceptions and medication adherence differ
by gender after controlling for confounders.

Methods
Design, setting, and sample. This was an observational cross-sectional research
study that used a non-probability sampling method to recruit participants. Participants
were recruited concurrently from four primary care clinics in the Houston, Texas
metropolitan area. One of the clinics was an employee health clinic affiliated with a
university. Thirty-nine percent (n = 46) of the participants were recruited from one
clinic, followed by another 29.7% (n = 35) from the second clinic, and 26.3% (n = 31)
from the third clinic. Enrollment from the fourth clinic, which was the employee health
clinic, was the lowest (5.1%, n = 6).
Inclusion criteria. The sample inclusion criteria were: (a) self-identified Black
adults; (b) males and females, aged 35 to 65 years; (c) diagnosis of primary/essential
hypertension (diagnosis of essential hypertension was confirmed by the principal
investigator [PI] during chart review, based on noting a written diagnosis of “essential” or
“primary” hypertension or an ICD 10 code (I10) in patients’ charts); (d) duration of
hypertension diagnosis of at least 12 months; (e) had been prescribed or was taking at
least one hypertensive medication; (e) ability to read and write in English.
Exclusion criteria. The exclusion criteria were: (a) secondary hypertension as
supported by history of sleep apnea, renal artery disease, stenosis, certain cardiovascular
diseases, hyperthyroidism, pregnancy, or adrenal gland tumor (pheochromocytoma) upon
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chart review; (b) severe mental disorder hindering comprehension of instructions; and (c)
refusal to provide informed consent.
Sample size estimate. Power analysis estimated sample size at 115 based on
power of .80, alpha of .05, and effect size of .07 using multiple regression. The primary
purpose of this study was to examine the relationship between illness perception and
medication adherence.
Instruments for data collection. Two validated questionnaires in addition to a
demographic data form were used in data collection. Participants completed the revised
Illness Perception Questionnaire (IPQ-R) (Moss-Morris et al., 2003) and the Hill-Bone
Blood Pressure Therapy Compliance Scale (Kim et al., 2000).
Illness Perception Questionnaire. Illness (hypertension) perception was
measured using the revised Illness Perception Questionnaire (IPQ-R), a scale that was
developed to quantitatively assess patients’ perception of illnesses across a range of
chronic diseases (Moss-Morris et al., 2002). The questionnaire was developed using the
constructs of the common-sense model as the theoretical framework. The IPQ-R consists
of two illness perception components, namely: Illness Representation (IR) and Causes.
The Identity component was not part of the revised IPQ-R, though it was only included
for the purposes of psychometric testing (Moss-Morris et al., 2002). In this study,
participants completed the hypertension version of this scale.
The IR component of the IPQ-R consists of 38 questions incorporated into seven
subscales, namely Timeline (acute/chronic), Cyclical Timeline
(episodic/temporary/unpredictable), Treatment Control, Personal Control, Consequences,
Illness Coherence, and Emotional Representations. Timeline (acute/chronic),
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Consequences, Personal Control, and Emotional Representations are represented by six
items on the questionnaire, while five items represent Treatment Control and Illness
Coherence. Finally, Cyclical Timeline is represented by four items on the questionnaire.
Each item is ranked on a Likert-type scale, with responses ranging from 1 (strongly
disagree) to 5 (strongly agree). High scores on the respective subscales supports beliefs
that hypertension is a chronic illness (Timeline), unpredictable/episodic (Cyclical
Timeline), can severely impact quality of life (Consequences), and that it can be
controlled by either personal behaviors (Personal Control) or by medical treatment
(Treatment Control) (Moss-Morris et al., 2002). The Coherence subscale represents good
personal understanding of the condition; thus, having a high score on a statement such as,
“I have a clear picture or understanding of my high blood pressure,” indicates a good
understanding of hypertension. The score from each subscale is summed to get a total
score for the respective subscales. The higher the score, the stronger the beliefs or views
about that dimension. There is no overall total score for the IPQ-R.
The Cause component of the IPQ-R contains an additional 18 short items, which
the developers recommend be used as a grouping variable through factor analysis when
there is sufficient sample size (85 or more) to identify the respective dimensions of
perception of cause of an illness, after which the groups can be used as subscales in the
analysis (Moss-Morris et al., 2002).
The validity of the IPQ-R was demonstrated through principal component
analysis, through which seven IR subscales and three causal attribution factors were
identified (Moss-Morris et al., 2002). The Cronbach’s alpha ranged from .79 to .89 for
the IR subscales and .67 to .86 for the causal items (Moss-Morris et al., 2002). Validity
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was further tested by a study that examined the association between hypertension
perception and self-care behavior among 111 Black hypertensive adults, 18 to 65 years,
and a reported Cronbach’s alpha ranging from .59 to .83 for the seven IR subscales,
where Treatment Control had the lowest internal consistency (Cronbach’s alpha .59),
followed by Personal Control (.63) and Consequences (.66) (Pickett et al., 2014).
Hill-Bone Blood Pressure Therapy Compliance Scale. The dependent variable
“medication adherence” was measured using the Hill-Bone Compliance to High Blood
Pressure Therapy Scale. The questionnaire was designed to assess patient behaviors for
three behavioral domains of high blood pressure therapy, including reduced sodium
intake, appointment keeping, and medication adherence (Kim, Hill, Bone, & Levine,
2000); however, only the medication subscale was used in this study since the focus was
on medication adherence. The total scale contains 14 items, grouped into three subscales,
of which eight items were related to questions about medication adherence; additionally,
one prescription-filling adherence question is often used together with the eight
medication-taking items by researchers. Each item on the scale is a four-point Likert
type scale (“4” equals “all the time” and “1” equals “none of the time”). The lower the
scores, the better the patient’s adherence level. According to the authors, the items are
assumed to be additive and when summed; thus, a score of nine on the medication
adherence subscale represents “perfect adherence” while a score of 36 denotes “perfect
non-adherence.”
Validity of the questionnaire was established through two studies: one utilized a
sample of 309 hypertensive Black males 18 to 55years old, while the other study used
718 Black hypertensive adults 18 years and older; the studies’ respective Cronbach’s
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alpha coefficients were .74 and .85 for the total (Kim et al., 2000). In addition, a study
with a sample of 80 Black women assessing the relationship between spirituality and
medication adherence reported a Cronbach’s alpha of .843 for the medication-adherence
subscale (Abel & Greer, 2017). A study with a sample of 190 urban Black men reported
a Crobanch’s alpha of .77 for the medication-adherence subscale of the questionnaire
(Kim, Han, Hill, Rose, & Roary, 2003). Validity through PCA using varimax rotation
extracted three subscales, though factor loading in both study 1 and 2 showed that the
medication-adherence subscale possessed the most meaningful and acceptable factor
loadings. Predictive validity showed that the summed scores of each subscale correlated
with blood pressure level and control (Kim et al., 2000).
Evidence of instruments reliability in present study. Reliability testing was
conducted to evaluate evidence of internal consistency of the IPQ-R subscales and the
Hill-Bone Blood Pressure Therapy Adherence Scale for the present study. After reverse
coding the negatively worded items on the IPQ-R questionnaire as recommended by the
developer (Moss-Morris et al., 2002), total scores were calculated for each of the seven
subscales of the IR in addition to the two subscales extracted from the causal attribution
items, making the total subscales from the IPQ-R questionnaire nine. Each of these
subscales was subjected to a reliability testing. Most of the subscales demonstrated
strong evidence of internal consistency reliability with a Cronbach’s alpha greater than .7
(Timeline =.86, Cyclical Timeline = .83, Consequences = .79, Illness Coherence = .83,
Emotional Representation = .83, Non-Biological Causal Views = .78, Psycho-Biological
Causal Views = .75). Two subscales that had slightly lower internal consistency were
Personal Control and Treatment Control, with Cronbach’s alpha coefficients of .68 and
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.66, respectively. These two subscales had the lowest internal consistency (Personal
Control = .63, Treatment Control = .59) in another study (Pickett et al., 2014).
Reliability testing of the Hill-Bone Medication Adherence Scale showed the
instrument demonstrated a strong internal consistency with a Cronbach’s alpha of .82. A
Cronbach’s alpha greater than .70 is acceptable evidence of reliability (Leech, Barrett, &
Morgan, 2015; Pallant, 2007).
Demographic data and confounding variables form. A short questionnaire was
designed to collect demographic data including age, educational level, health insurance,
and employment status. The demographic data form was also used to collect data about
covariate or confounding variables anticipated to impact both illness perceptions and
medication adherence, including duration of hypertension diagnosis, educational level,
experiencing worrisome hypertension-related symptoms (yes or no responses), number of
blood pressure medications, severity of hypertension, and history of depression
(comorbidity) diagnosed by a healthcare provider. History of depression was based on a
“yes or no” responses as well as verified through chart review and noting prescribed
depression medications. Severity of hypertension was categorized into two stages based
on blood pressure classification by the Joint National Committee on Prevention,
Detection, Evaluation, and Treatment of Hypertension ([JNC], 2003): stage 1 = 140159/90-99 and stage 2 =≥ 160/≥100, where stage 1 represents mild hypertension, and
stage 2 represents severe hypertension. For the purposes of this study, blood pressure
readings below 140/90 were considered normal, thus creating a third category in this
study. Blood pressure readings recorded in each participants’ chart during two separate
doctor’s visits were averaged and used in categorizing severity of hypertension. The two
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blood pressure readings or doctors’ visits were generally three months apart. For most of
the participants, the two blood pressure measurements used were from the readings in the
chart on the day of data collection and the readings from the prior visit, three months
before.
Procedures. Participants were approached in the clinics’ lobbies by the PI with
the recruitment flyer as they presented for their regular medical appointments with their
healthcare providers. Furthermore, the PI verbally explained the study and allowed each
participant time to ask questions. Individuals who agreed to participate were asked to
complete the questionnaires after signing consent. The questionnaires were mostly selfadministered; three to four participants asked their accompanying family members or the
PI to read the questions and response options to them while they verbally indicated which
options they chose. Each participant received a $15 gift card upon completion of the
questionnaires. A chart review was conducted at the end of each recruitment day to
gather information about the number of medications participants were taking for their
blood pressure, blood pressure readings, duration of hypertension, and any documented
history of depression, as these data served as covariates in the analyses. Additionally,
diagnosis of essential or primary hypertension or presence of secondary hypertension
were confirmed through chart review. Most of the data on the duration of hypertension
was based on the participants’ report since patients’ medical records do not often have the
most reliable information about when the patient was diagnosed with hypertension,
unless the diagnosis was initially established at that clinic. The PI is an experienced
family nurse practitioner in active practice, thus possessing the clinical knowledge to
comprehend information and data in participants’ charts, including diagnoses, diagnosis
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codes, and class of medications used for hypertension and/or other cardiac conditions as
well as for depression and/or other mental health disorders.
Statistical analyses. All data analyses were conducted using IBM’s Statistical
Package for Social Sciences (SPSS) software, version 24. The sociodemographic
characteristics of the sample and distributions of the continuous variables were examined
with descriptive statistics. Univariable analyses were conducted to check for associations
of medication adherence with each of the predictor (illness perceptions subscales)
variables and potential confounding variables. Reliability testing was conducted to
examine the internal consistency of the IPQ-R subscales (IR and Cause subscales) for the
current sample as well as for the outcome variable (medication adherence).
To address the first aim of this study, a principal component factor analysis with
varimax rotation was conducted using the 18 causal items of the IPQ-R to identify the
sample’s causal attribution dimensions, after which the extracted subscales were used in
combination with other IPQ-R (IR) subscales to conduct the multiple regression analysis
in Aim #2. Conducting a factor analysis with the present sample became important
because the samples used by existing studies that conducted previous factor analysis on
the causal items of the IPQ-R were somewhat different from the present sample. The
first factor analysis was by the developer of the scale (Moss-Morris et al., 2002) using a
sample of adults with various medical illnesses but did not explicitly indicate the racial
demographics of the sample; in addition, the sample was recruited from Europe. Another
study by Pickett et al. (2014) conducted principal component factor analysis using a
sample of Black hypertensive adults 18 to 65 years with lower educational level than the
present sample and who were recruited from shopping malls, public housing apartments,
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and community clinics. Recruitment for the present study was more structured, with
diagnosis of essential or primary hypertension was verified through chart review;
additionally, over half of the sample had a four-year college degree or higher. These two
previous studies did not provide explicit explanation or steps on how factor selection
decisions were made.
In the present study, the decision to assign an item to a factor was based on a
priori criteria of factor loadings greater than or equal to .40 and for items cross-loading
high into two factors; if the difference between the loadings was less than or equal to .20,
the item was retained and assigned to the factor with the higher or highest loading; but if
the difference was less than .20, the item was not assigned to any factor (Ferguson &
Cox, 1993). An acceptable loading for each factor was at least three items (Watson &
Thompson, 2006).
To address the second but primary aim of the study, a multiple regression was
conducted to test the relationships between medication adherence and perceptions about
hypertension timeline, controllability, consequences, emotional representation, illness
coherence, and cause among Black hypertensive adults 35 to 65 while controlling for the
covariates (age, educational level, and experience of hypertension-related symptoms) that
demonstrated acceptable correlation with the dependent variable (medication adherence).
Preliminary univariable analyses were conducted to ensure that assumptions of
multiple regression were not violated (linearity, normal distribution, and uncorrelated
errors). Initial descriptive analyses conducted on the dependent variable (medication
adherence) revealed evidence of high kurtosis (3.202; SE = .442) or skewed distribution
of scores; thus this variable was subjected to a natural log transformation, leading to a
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more normal score distribution with a Kurtosis score of .213 (SE = .442). Next a
univariable analysis was conducted using Pearson correlation coefficients to examine the
relationship between the dependent variable (medication adherence) and the nine
subscales of the IPQ-R (Timeline, Cyclical Timeline, Consequences, Illness Coherence,
Emotional Representation, Lifestyle and Uncontrollable Causal Views, PsychoBiological Causal Views, Personal Control, Treatment Control).
Only two subscales of the IPQ-R had statistically significant positive correlation
with medication adherence: Cyclical Timeline (r = .246, p = .007) and Emotional
Representation (r = .179, p = .05); however, at the recommendation of the statistician,
variables with a non-significant statistical correlation (greater than .05 but less than .1)
with medication adherence were retained to be included in the model in order to prevent
premature elimination of predictor variables that could potentially make a significant
contribution to the variance in the multiple regression model. For this reason, the
Consequences subscale, which had a negative relationship with medication adherence (r
= -159, p = .085), was retained for inclusion in the model. In total, only three out of the
nine IPQ-R subscales were included in the multiple regression model.
Univariable analyses were conducted to evaluate the correlation between each of
the covariates (depression, educational level, age, duration of hypertension diagnosis,
experience hypertension-related symptoms, and severity of hypertension) and the
dependent variable (medication adherence). Using Pearson correlation coefficients, age
was found to have a significant negative correlation with medication adherence (r = -260,
p = .004). The older one is, the lesser their score on medication adherence—meaning the
older one is, the more adherent they are since a lower score on medication adherence
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connotes better adherence to medication. Using independent sample t-tests, there was a
statistically significant association between experience of worrisome hypertension-related
symptoms and medication adherence scores (t (116) = 3.06, p = .003). Those
experiencing worrisome hypertension symptoms had higher mean scores on medication
adherence (M = 2.6, SD =. 26) than those not experiencing worrisome hypertensionrelated symptoms (M = 2.4, SD =.24). This result indicates that those who experienced
worrisome hypertension symptoms had worse medication adherence than those that did
not experience worrisome hypertension symptoms. Furthermore, using an independent
sample t-test, history of depression did not affect medication adherence scores (p = .089).
Using the one-way ANOVA, educational level was found to have a statistically
significant relationship with medication adherence (p = .007). The less education one
has, the higher their scores on medication adherence, meaning they are less adherent. No
statistically significant relationships were found between number of hypertension
medications, duration of hypertension and severity of hypertension and medication
adherence; thus these covariates were not included in the initial multiple regression
model.
Finally, individual ANCOVA analyses were conducted to explore gender
differences in medication adherence and illness perception scores among the nine IPQ-R
subscales. Potential effects of certain covariates were controlled for during ANCOVA
for the IPQ-R subscales that demonstrated significant correlations with any or all the
covariates at p < .05 for the IPQ-R subscales that had no significant correlation with any
of the covariates. ANCOVA was conducted without controlling for any covariates since
the aim is to explore gender differences in scores.
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Univariable analyses was conducted to evaluate the correlation between the
respective dependent variables (the nine IPQ-R subscales) and each of the covariates to
be controlled for in ANCOVA (age, educational level, and duration of hypertension)
since ANCOVA requires that each of the covariates should be significantly correlated
with the dependent variable (Pallant, 2007). Homogeneity of regression slopes, which
requires that the relationship between the covariate and the dependent variable for the
grouping variable (gender) is the same (an assumption of ANCOVA), was tested (Pallant,
2007). For the IPQ-R subscales that had no significant correlation with any of the
covariates, ANCOVA was conducted without controlling for any covariates to explore
gender differences in scores.

Results
Sample characteristics. The PI approached a total of 200 participants from four
primary care clinics over a ten-week period for recruitment into the study. Ten
participants who met inclusion criteria declined participation due to outright non-interest,
being in a hurry, or complaint that study questionnaire was too long. Seventy participants
did not meet inclusion criteria due to age lower than 35 or greater than 65 years, history
of hypertension less than one year, or having no history of hypertension. A total of 120
participants signed consent and completed study questionnaires, however, upon chart
review, two participants were excluded due to history of sleep apnea or renal artery
disease. Finally, data from a total of 118 participants were included in the analyses.
Table 1 depicts the descriptive statistics for the continuous variables, while Table
2 depicts the sample’s categorical demographic characteristics. The total sample size was
118. Participants were middle aged (M = 53.9 years; SD = 7.88 years), and males made
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up 52.5% (n = 62) of the sample. Participants were generally educated; with 51% having
a four-year degree or higher; with only 1.7% (n = 2) having less than a high school
education.
Duration of hypertension ranged from 1 to 40 years (M = 10.09; SD = 7.43).
Overall, 42% (n = 50) had normal systolic blood pressure (SBP < 140; 34.7% [n = 41]),
had mild or stage 1 hypertension (SBP 140 to ≤ 159), while 22.9% (n = 27) had severe
(stage 2) systolic hypertension (SBP ≥ 160mm Hg), with 8.5% (n = 10) having severe
diastolic hypertension (DBP ≥ 100mmHg).
Thirty-seven (31.4%) of the sample experienced worrisome hypertension-related
symptoms. Only 16.1% (n = 19) had a history of depression. Most (91.5%, n = 108) of
the sample indicated they have health insurance that pays for their medications and
doctors’ visits. The sample was mostly (69.5%, n = 82) employed with only 13.6 % (n =
16) indicating they were retired.
Descriptive statistics for the IPQ-R subscales are included in Table 1. Items for
both the illness representation (IR) and the causal subscales of the IPQ-R were scored on
a 5-point Likert scale with scores ranging from 1 (strongly disagree) to 5 (strongly agree)
and summed to obtain subscale scores. The varying number of items in each subscale
was considered in evaluating and comparing the strength of respondents’ perceptions
across the subscales by dividing each of the subscale scores by the number of items,
resulting in the average item response for the subscale on a scale of 1 to 5. The sample
agreed that that hypertension can be controlled through personal endeavor (Personal
Control: M = 4.1) and by prescribed medical treatment (Treatment Control: M = 4.0).
The sample neither agreed nor disagreed on whether they have a coherent understanding
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of their hypertension (Illness Coherence: M = 3.8), that hypertension is caused by a
combination of psychological and biomedical risk factors (Psycho-Biomedical Causal
Views: M = 3.3), that hypertension is a burden on their lives (Consequences: M = 3.0),
and is a chronic condition (Timeline,: M = 3.1). The sample, however, disagreed that
hypertension is unpredictable (Cyclical Timeline: M = 2.8), that factors related to
unhealthy lifestyle choices and uncontrollable factors (Lifestyle and Uncontrollable
Causal Views: M = 2.2), or that hypertension instigates emotional reactions (Emotional
Representation: M = 2.6).
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Table 1
Continuous Variables: Descriptive
n

Minimum

Maximum

Mean

Standard
Deviation

Age

118

37

65

53.85

7.881

HTN Duration (Years)

118

1

40

10.09

7.433

Timeline

118

6

30

18.28

5.6

Cyclical Timeline

118

4

20

11.4

3.9

Consequences

118

9

26

16.97

3.9

Personal Control

118

14

30

24.8

3.5

Treatment Control

118

12

25

20

3.1

Illness Coherence

118

8

25

19.2

3.9

Emotional Representation

118

6

30

15.6

4.87

Lifestyle and Uncontrollable 118
Causal Views

7

27

15.2

5.09

Psycho-Biomedical Causal
Views

118

7

35

23.02

5.34

Medication Adherence

118

9

27

12.1

3.44
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Table 2
Categorical Demographic Variables
Variable
Gender

Education

Average Systolic
Blood Pressure

Average Diastolic
Blood Pressure

Experience Worrisome
HTN Symptoms
Depression History

Health Insurance

Employment Status

Frequency

Percent

Male

62

52.5

Female

56

47.5

Less than high school

2

1.7

High school

20

16.9

Some college or trade
school

36

30.5

Four-year college or
higher

60

50.8

140 – 159 (mild)

41

34.7

160 or greater (severe)

27

22.9

Less than140 (normal)

50

42.4

90 - 99 (Mild)

23

19.5

100 or greater (severe)

10

8.5

Less than 90 (normal)

85

72

Yes

37

31.4

No

81

68.6

Yes

19

16.1

No

99

83.9

Yes

108

91.5

No

10

8.5

Employed

82

69.5

Unemployed

20

16.9

Retired

16

13.6
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Hypertension causal attributions. The first objective of this study was to
explore the sample’s perceptions about cause of hypertension. The hypothesis was that
perception of psychological factors as cause of hypertension will explain the highest
variance in causal attributes of hypertension among other factors.
To examine this aim and hypothesis, the 18 causal items of the revised Illness
Perception Questionnaire (IPQ-R) were subjected to a principal component factor
analysis (PCA) in SPSS. Prior to conducting the analysis, the adequacy of the data for
factor analysis was evaluated. The Kaiser-Meyer-Oklin value was .73, which exceeds the
recommended value of .6 (Kaiser, 1970, 1974 as cited by Pallant, 2007), while Bartlett’s
Test of Sphericity was statistically significant (p = .000).
The initial PCA without rotation identified five causal factors with eigenvalues
greater than one. These factors were further examined with PCA with varimax rotation,
which extracted five components with eigenvalues greater than one, explaining 17.8%,
17.5%, 9.9%, 7.8% and 7.9% of the variance respectively, with an approximate
cumulative total of 63% of the variance explained. However, the scree plot suggested a
somewhat weak break after the third component. Upon evaluation of the rotated
component matrix of the five-factor solution, while also examining factor loadings, crossloadings, and number of items loading on each factor, only three factors met the study’s a
priori criteria for factor retention; however, this three-factor solution had a large number
of items with high cross-loadings on different factors. To further evaluate these three
factors, another PCA with varimax rotation was conducted specifying a fixed three-factor
solution. The three-factor solution had eigenvalues exceeding one, explaining 18.9%,
17.7%, and 13.1% of variance causal attributions respectively, with a cumulative 49.7%
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of variance explained. However, the rotated component matrix revealed many crossloadings that did not meet the set a priori criteria for item inclusion into a factor,
especially on factor 3, which left factor 3 with less than three items loading high in it.
The number of items loading in each factor, in addition to the scree plot that showed a
sharp break after the second component suggested that a two-factor solution could be a
better representation of the causal attributions of the IPQ-R. A final PCA with varimax
rotation specifying a fixed two-factor solution resulted in eigenvalues greater than one.
The two factors explained 22.7% and 18.1% of the variance in causal attribution
respectively, with a cumulative 40.8% variance explained. Each of these two factors were
comprised of seven items with high loadings and only minimal cross-loadings. The
rotated component matrix (Table 3) revealed that two items (“my mental attitude” and
“my emotional state”) cross-loaded high into the two factors and did not meet the criteria
to be assigned to any factor; additionally, two items (“ageing” and “chance or bad luck”)
did not load high in any factor; thus these four items were not included in the factor
assignment.
An oblique rotation with Promax also revealed the same result as the varimax
rotation outlined above. The items loading in these two factors provide the most
conceptually coherent explanation or representation of the causal views. This result
shows that sample’s views about cause of hypertension clustered around two factors,
namely:
Factor 1. This factor, Lifestyle and Uncontrollable Causal Views, included
smoking, alcohol, accident, personality, altered immunity, pollution in the environment,
germs, or viruses. Items that loaded into this factor include items related to unhealthy
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lifestyle choices, such as smoking and alcohol use, in addition to factors outside an
individual’s control, such as personality, pollution in the environment, accident, altered
immunity, or germs. Examination of the items loading into this factor seemed to
represent factors that are either not associated with hypertension or are not always
identified as standard risk factors. Excessive alcohol intake and smoking, though
recognized as risk factors for hypertension by the biomedical community (AHA, 2017d),
may not be viewed by lay individuals as risk factors for hypertension.
Factor 2. This factor was labeled Psycho-Biomedical Causal Views. Items that
loaded into this factor are factors related to life stressors or psychological issues such as
stress, overwork, behavior, family problems, and known risk factors for hypertension,
such as family history, poor medical care, and diet or eating habits. Known predisposing
risk factors for hypertension and stress-inducing items clustered together in this factor.
Dietary habits, especially a high-sodium diet, are a very important known risk factor for
hypertension (AHA, 2017d). The bulk of the self-care education that healthcare providers
often give to hypertensive patients, especially Blacks, relating to diet lies on reducing
sodium intake; higher intake of sodium is associated with an increase in blood pressure
among Blacks (Wright et al., 2003). This common advice may explain why this item
loaded into the second factor with the rest of the known risk factors for hypertension in
this sample.

71
Table 3
Rotated Component Matrix

Variance Explained
Items

22.7%

18.1%
Component
1

2

Accident or injury

.812*

-.029

My personality

.757*

.089

Altered immunity

.735*

-.102

Smoking

.666*

.102

Alcohol

.596*

.162

My emotional state

.582#

.396#

Pollution in the environment

.451*

.212

Germ or virus

.420*

-.066

Ageing

.387@

.125

Chance or bad luck

.240@

.096

-.034

.674*

.331

.648*

-.003

.626*

Family problems or worries

.367

.606*

Diet or eating habits

.054

.604*

My mental attitude

.544#

.586#

.181

.566*

-.063

.560*

Stress or worry
Overwork
My own behavior

Poor medical care in my past
Hereditary—it runs in the family

Note.
*: items loaded strongly in factor 1 or 2
#: Items cross-loading in factor 1 and 2 not meeting cross-loading criteria
for factor assignment
@: Items loading low on the 2 factors.

72
Relationship between medication adherence and hypertension perceptions.
The primary objective of this study was to examine whether there is any relationship
between medication adherence and perceptions about hypertension timeline,
controllability, consequences, emotional representation, illness coherence, and causal
attributions among Black hypertensive adults 35 to 65 while controlling for depression,
educational level, age, duration of hypertension diagnosis, experience of hypertensionrelated symptoms, and severity of hypertension. The hypothesis was that there will be a
statistically significant relationship between medication adherence and hypertension
perceptions, where high scores on the subscales of the IPQ-R will be associated with
higher scores on medication adherence.
Three of the IPQ-R subscales were significantly (p < .10) positively correlated
with medication adherence, including Cyclical Timeline (r = .246, p = .007), Emotional
Representation ( r = .179, p = .05), and Consequences (r = -159, p = .085); these were
included in the multiple regression model (Table 4).
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Table 4
Correlation between IPQ-R subscales and medication adherence
Independent Variables

Medication Adherence
(Dependent Variable)

Timeline

r = -.071; p =.446

Cyclical Timeline

r =.246; p = .007*

Consequences

r = -.159; p = .085*

Personal Control

r =-.130; p = .161

Treatment Control

r = -.058; p =.536

Illness Coherence

r = -.058; p = .534

Emotional Representation

r = .179; p = .053*

Lifestyle and Uncontrollable Causal
Views

r = .081; p =.381

Psycho-Biomedical Causal Views

r = .092; p = .321

Note. *IPQ-R subscales with statistical correlation with medication adherence at p<.1
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Hierarchical multiple regression was conducted to examine the ability of the three
IPQ-R subscales (Cyclical Timeline, Emotional Representation, and Consequences) to
predict levels of medication adherence while controlling for age, educational level, and
experience of worrisome hypertension-related symptoms. The covariates (educational
level, age, and experience of worrisome hypertension symptoms) were entered in step 1
(model 1), which explained 18.1% of variance in medication adherence. After entering
the three predictor variables (Cyclical Timeline, Consequences, and Emotional
Representation) in model 2, the model (Table 5) together explained a total of 23.9%
variance in medication adherence, F (6, 111) = 5.821, p < .001. The three predictor
variables (Cyclical Timeline, Consequences, and Emotional Representation), explained
an additional 5.8% of variance in medication adherence after controlling for age,
educational level, and experience of worrisome hypertension symptoms, R2 change =
.058, F change (3, 111) = 2.84, p = .041. In the final model, only age (beta = -.190, p =
.033), educational level (beta = -.232, p = .007), and Consequences (beta = -.203, p =
.022) made significant statistical contribution to the variance in medication adherence
(Table 5). Of the three IPQ-R subscales entered in the model, only Consequences
demonstrated a significant statistical relationship with medication adherence. The result
indicates that the stronger the sample believes that hypertension has consequences, the
lesser their scores on medication adherence (meaning higher adherence).
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Table 5
Multiple regression: Model summary and coefficients
Change Statistics

Model
2

R

R

2

Std. Error
Adjusted
of the
R2
R2
Estimate Change

.489b .239 .198

.22615

Model
2
(Constant)
Age
Educational Level
Experience Worrisome
HTN Symptoms
Cyclical Timeline
Consequences
Emotional representation

.058

F Change
2.838

df1
3

Sig. F
df2 Change
111 .041**

Unstandardized
Standardized
Coefficients
Coefficients
Std.
B
Error
β
t
Sig.
3.158
.225
14.008 .000
-.006
.003
-.190
-2.158 .033*
-.072
.026
-.232
-2.724 .007*
-.069
.049
-.128
-1.402 .164
.010
-.013
.006

.006
.006
.005

.149
-.203
.120

1.657 .100
-2.327 .022*
1.308 .194

Note. ** Level of model 2’s statistical significance(p<.05) when the three IPQ-R subscales were
added into the model.
*Variables that individually significantly predicted medication adherence.

Overall model significance: p = .000c
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Gender difference in hypertension perceptions and medication adherence.
Individual ANCOVA was conducted to test for gender differences using each of the nine
IPQ-R subscales as dependent variables while controlling for covariates when applicable.
Age had a significant statistical correlation with Timeline, Cyclical Timeline, Treatment
Control, Personal Control, and Psycho-Biomedical Views (Table 6) and thus was
controlled for in their respective analyses. Duration of hypertension had a significant
statistical relationship with Timeline, Illness Coherence, and Personal Control (Table 6)
and was controlled for during the analyses. Educational level had a statistically
significant correlation with Treatment Control (Table 6) and thus was controlled for in
the analysis.
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Table 6
Correlation between IPQ-R subscales and covariates for ANCOVA
Variable

Age

Duration of
Hypertension

Education Level

r =.200, p =.030*

r = .218; p =.018*

F =.400; p =.753

r = -218; p =.018*

r =-.049; p =.598

F =.932; p =.428

Consequences

r =.002; p =.980

r =.093; p =.316

F =.980; p =.405

Personal Control

r =-222; p =.016*

r =-.179; p =.052*

F =1.656; p =.181

Treatment Control

r =-190; p =.040*

r =-.147; p =.111

F =2.732; p =.047*

Illness Coherence

r =-167; p =.070

r =-.185; p =.045*

F =.287; p =.834

Emotional
Representation

r = -128; p =.168

r =-.077; p =.406

F =.155; p =.926

Lifestyle and
Uncontrollable
Causal Views

r =.056; p =.547

r =.083; p =.371

F =.244; p =.865

Psycho-Biomedical
Views

r =-234; p =.011*

r =-.085; p =.359

F =.983; p = .403

Timeline
Cyclical Timeline

Note. * Covariates with statistically significant(p<.05) correlation with the respective IPQ-R
subscales
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The final objective of this study was to explore to what extent hypertension
perceptions (Aim 3a) and medication adherence (Aim 3b) differ by gender, while
controlling for certain confounding variables. Aim 3a sought to explore gender
differences on the scores of the IPQ-R subscales while controlling for educational level,
age, and duration of hypertension diagnosis.
Homogeneity of regression slopes, an assumption of ANCOVA that requires that
the relationship or interaction between the covariate and the dependent variable for each
group (gender) to be the same, was conducted (Pallant, 2007) (Table 7). This test was
only conducted between the IPQ-R subscales and the covariates they demonstrated
significant statistical correlation with; those IPQ-R subscales without any significant
correlation with any covariates did not undergo homogeneity testing.
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Table 7
Homogeneity of regression slopes: Interaction
Variable

Gender * Age

Gender *
Hypertenion
Duration

Gender * Education

Timeline

F =.103; p =.749

F = .605; p =.438

N/A

Cyclical Timeline

F = .017; p =.898

N/A

N/A

Personal Control

F = .953; p =.331

F = .078; p =.780

N/A

Treatment
Control

F =1.803; p =.182

N/A

F =2.431; p = .122

PsychoBiomedical
Causal Views

F = .158; p = .692

N/A

N/A

Illness Coherence

N/A

F =.578; p =.449

N/A

Consequences

N/A

N/A

N/A

Emotional
Representation

N/A

N/A

N/A

Lifestyle and
Uncontrollable
Causal Views

N/A

N/A

N/A
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As Table 8 depicts, individual ANCOVA analyses showed no statistical
significant gender differences in Timeline (p = .532) and Personal Control (p =. 625)
scores while controlling for age and duration of hypertension, or in Cyclical Timeline (p
= .517) and Psycho-Biomedical Causal Views (p = .145) scores while controlling for age.
Furthermore, no statistically significant gender differences in Treatment Control scores
while controlling for age and educational level (p = .734); and no significant statistical
gender difference in Illness Coherence scores while controlling for duration of
hypertension (p = .578).
Additionally, individual ANCOVA was conducted for Consequences, Emotional
Representation, and Lifestyle and Uncontrollable Causal Views without controlling for
any covariates since these three IPQ-R subscales demonstrated no significant statistical
correlations with any of the covariates of interest (age, hypertension duration, and
educational level). There were no statistically significant gender differences in
Consequences or Emotional Representation scores, but there was a statistically
significant gender difference in Lifestyle and Uncontrollable Causal Views scores (Table
8). Compared to females (M = 14.196), males had a significantly higher adjusted mean
score (M = 16.183, p = .034) on the perception or belief that hypertension is caused by
factors related to a combination of poor lifestyle choices, such as smoking and alcohol
use, and uncontrollable factors, such as immunity, germs, accidents, and pollution in the
environment.
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Table 8
Adjusted mean scores and standard error: Gender differences in hypertension
perceptions (nine IPQ-R subscales):

Variable

Timeline

Cyclical
Timeline

Mean
Score

Std.
Error

95% CI
Lower
Bound

Upper
Bound

18.596a .713

17.184

20.008

Female 17.937a .751

16.449

19.425

11.215a .495

10.235

12.196

Female 11.690a .522

10.657

12.723

24.946a .437

24.080

25.813

Female 24.631a .461

23.718

25.544

20.095a .395

19.313

20.877

Male

Male

Personal Control Male

Treatment
Control

Male

PsychoBiomedical
Causal Views

Male

Illness
Coherence

Male

Female 19.429a .515

18.410

20.449

Consequences

Male

Female 19.895a .416

19.070

20.719

23.705a .669

22.380

25.030

Female 22.256a .705

20.859

23.652

19.031a .489

18.063

20.000

16.813

.502

15.818

17.807

Female 17.150

.528

16.104

18.196

Emotional
Representation

Male

15.484

.622

14.252

16.715

Female 15.714

.654

14.418

17.010

Lifestyle and
Uncontrollable
Causal Views

Male

16.183

.637

14.921

17.445

Female 14.196

.670

12.869

15.524

Sig.

Variables
Controlled
for

p =.532

Age and
HTN
Duration

p = .517

Age

p =. 625

Age and
HTN
Duration

p = . 734

Age &
Education

p = . 145

Age

p =.578

HTN
Duration

p =.645

None

p =.799

None

p =. 034* None

Note. * Variable(s) with statistically significant(p<.05) gender difference in mean scores.
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For Aim 3b, ANCOVA was conducted to evaluate whether there was any gender
difference in medication adherence scores while controlling for age, number of
medications, educational level, and comorbidity (depression). Age was not included as a
covariate in this analysis as the interaction between age and gender was significant (p =
.007), which violates the assumption of homogeneity of regression slopes (Leech, Barrett,
& Morgan, 2015; Pallant, 2007). Additionally, “number of hypertension medications”
taken was not included because the univariable analysis showed it had no significant
statistical correlation with the outcome variable (medication adherence). The result
showed that there was no statistically significant difference between genders in
medication adherence scores after controlling for depression and educational level (Table
9).
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Table 9
Gender differences in medication adherence: Test of between-subjects effects
Type III Sum
of Squares

df

Mean
Squared

F

Sig.

Partial
η2

Corrected
Model

.673a

3

.224

3.766

.013

.090

Intercept

25.444

1

25.444

427.154

.000

.789

Education

.488

1

.488

8.187

.005

.067

Depression
History

.092

1

.092

1.546

.216

.013

Gender

.012

1

.012

.197

.658*

.002

Error

6.791

114

.060

Total

722.296

118

7.464

117

Source

Corrected
Total

Note. * Non-statistically significant gender difference in medication adherence scores
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Discussion
The present study first sought to investigate the factor structure of hypertension
causal attribution among Black hypertensive adults aged 35 to 65 years. The second but
primary objective was to examine whether there is an association between hypertension
perceptions and medication adherence among Black hypertensive adults after controlling
for the effects of certain confounders, and the final objective was to explore gender
differences in hypertension perceptions and medication adherence.
Hypertension causal attributions. First, the factor structure of causal
attributions of hypertension was tested. Two factors of hypertension causal attribution
were identified. The first factor was labeled “Lifestyle and Uncontrollable Causal
Views,” while the second factor was labeled “Psycho-Biomedical Causal Views.” These
two causal attribution subscales demonstrated acceptable internal consistency reliability.
The hypothesis was that psychological attribution of cause of hypertension would
explain the highest variance in causal attributions, however, the Lifestyle and
Uncontrollable Causal View as the cause of hypertension explained more variance
(22.7%) in causal attribution of hypertension than the Psycho-Biomedical View, which
explained 18% of variance. The results showed that items related to psychological
factors as a cause of hypertension clustered together with known hypertension
predisposing risk factors. Based on the a priori factor selection criteria used in this study,
the IPQ-R causal attributional component can be considered as two conceptually
meaningful subscales for middle-aged Black adults with hypertension who have access to
primary care, but studies to replicate this in other samples are recommended.
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Though Lifestyle and Uncontrollable Causal Views explained the highest
variance in causal hypertension attribution among this sample, on a 1 (strongly disagree)
to 5 (strongly agree) scale, the mean subscale score for the Psycho-Biomedical Causal
View was higher than the mean score for Lifestyle and Uncontrollable Causal View
subscale. The sample neither agreed nor disagreed that a combination of
psychological/life stressors and known hypertension risk factors caused their
hypertension; however, the sample disagreed that hypertension is caused by a
combination of unhealthy lifestyle choices and factors outside their control.
In contrast with the present study, Pickett et al. (2014) used a sample of 111 Black
hypertensive adults and extracted five factors and reported that psychological or life
stressor related items loaded together into the same factor and explained the most
variance. This was followed by views that hypertension is caused by factors outside an
individual’s control, such as germs, altered immunity, chance, or accident; however,
known or standard risks factors for hypertension such as aging, poor medical care, and
family history seemed to have loaded into different factors without a clear or coherent
conceptual definition. Additionally, the developer (Moss-Morris et al., 2002) of the IPQR extracted four causal attribution subscales where the psychological items clustered
together and explained the most variance, followed by known risk factors for
hypertension and items related to poor immunity clustered in respective factors.
The present study’s causal attribution contrasts from other studies in that both
standard hypertension risk factors and psychological/life stressors loaded together in the
same factor. Previous studies, both qualitative and quantitative, have mostly reported
that perceptions about cause of hypertension among Black adults have often centered
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around stress/psychological models versus biomedical models (Heckler et al., 2008;
Lukoschek, 2003; Wilson et al., 2002; Heurtin-Roberts & Resisin, 1990); however, a
new finding from the present study is that there may be a shift with this population, or
subgroups within it, which is beginning to view the cause of hypertension within a model
that encompasses both the psychological/stress and biomedical models together.
The contrast in the present study’s causal attribution result could be due to the sample’s
higher educational level, age, and the use of a more structured recruitment strategy
compared with previous studies.
Although two causal attribution factors were identified in this study with the
Lifestyle and Uncontrollable Causal Views factor explaining the most variance, a look at
the individual subscale mean score on these two factors clearly indicates that the sample
does not believe that hypertension is caused by factors related to unhealthy lifestyle such
as smoking and alcohol in combination with factors outside their control. The sample,
however, neither agreed nor disagreed that a combination of life stressors and known risk
factors for hypertension caused their hypertension. This finding suggests that the sample
has some level of ambivalence regarding the cause of hypertension. Several old
qualitative studies have reported misconceptions about hypertension among Black
hypertensive adults that are related to believing that psychological factors rather than
biomedical factors cause hypertension (Boutin-Foster, Ogedegbe, Ravenell, Robins, &
Charlson, 2007; Ogedegbe et al., 2004; Schlomann, & Schmitke, 2007; Wilson et al.,
2002); however, in the present study these two factors clustered together.
Relationship between medication adherence and hypertension perceptions.
The second but primary aim of this study was to examine whether there would be any
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relationship between medication adherence and perceptions about hypertension timeline,
controllability, consequences, emotional representation, illness coherence, and cause
among Black hypertensive adults 35 to 65 while controlling for depression, educational
level, age, duration of hypertension diagnosis, experience of hypertension-related
symptoms, and severity of hypertension. The hypothesis that there would be a
statistically significant relationship between medication adherence and hypertension
perception, where high scores on the subscales of the IPQ-R would be associated with
better medication adherence scores, was partially supported.
Only three of the nine perception subscales IPQ-R (Cyclical Timeline,
Consequences, and Emotional Representation) demonstrated a statistical correlation with
the outcome variable (medication adherence) and were included in the multiple
regression model; only one subscale, Consequences, had a statistically significant
association with medication adherence. Consequences appears to be a strong predictor of
medication adherence; though additional variance explained by the addition of the three
IPQ-R subscales into the model was small (5.8%), it was significant (p = .041). The
stronger the sample’s belief that hypertension is a disease that increases burden on one’s
life, the better their medication adherence. It is very possible that stronger belief that
hypertension has consequences predicted medication adherence in this sample due to
existing knowledge or personal experiences of the burden of hypertension on their lives
or those of their friends or family members. The other two subscales (Emotional
Representation and Cyclical Timeline) may not have been significant predictors of
medication adherence among this sample because the sample may have had hypertension
long enough to believe that their hypertension is rather predictable and does not instigate
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any emotional reactions that prompt engaging in coping behavior, such as medication
adherence. This is consistent with the result of the subscale mean scores discussed
earlier, which revealed that this sample does not believe that hypertension is a disease
that is unpredictable or induces any emotional reaction. This also suggests that this
sample may have a good understanding of their hypertension. As noted earlier, the
sample have a strong belief that their high blood pressure can be controlled by their selfefficacy (personal control) and treatment control; thus they do not experience any
emotional upset regarding their disease.
This result provides partial support for the hypothesis that hypertension
perception will be associated with medication adherence. The finding of this study has
lent credence to findings from previous studies where views about hypertension,
especially cause, were found to guide self-management behavior among Black
hypertensive adults (Heckler et al., 2008; Heurtin-Roberts & Reisin, 1990). Additionally,
the study by Pickett et al. (2014) examined the association of illness perceptions and
medication adherence among Black adults found that illness coherence was a predictor of
self-care behaviors (F = 7.10, p < .01). Ross et al. (2004) explored the role of illness
perceptions and treatment beliefs in medication adherence among hypertension patients
in the United Kingdom and reported that emotional representation (p = .01) and personal
control (p = .01) significantly predicted medication adherence. A study by Chen, Tsai,
and Lee (2009) among Taiwanese hypertensive adults reported that treatment control,
risk factors, and psychological attribution predicted medication adherence.
Additional findings of the current study were that both age and educational level
had statistically significant predictive association with medication adherence, thus
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justifying the need to use them as covariates in the multiple regression analysis. The
older the participant, the better their medication adherence; and the higher their
educational level, the better their medication adherence. Heckler et al. (2008) and Ross,
Walker, and Macleod (2004) also noted an association between medication adherence and
age. Nevertheless, with covariates and the three subscales noted above in the model, only
23.9% of the variance in adherence was explained.
Because most of what is known about hypertension perceptions and medication
adherence among Black adults has been based on qualitative studies with samples that
were majority female, the third and final aim of the present study was to explore whether
there were any gender differences in illness perceptions and medication adherence.
The results showed only the Lifestyle and Uncontrollable Causal Views of
hypertension demonstrated a statistically significant gender difference; compared to
women, men had a slightly stronger belief in this factor as a cause of hypertension. There
were no statistically significant gender differences on the scores of the other eight IPQ-R
subscales or on the adherence scale, indicating that males and females were similar in
their perceptions of hypertension and their reports of antihypertensive medication
adherence. Ross et al. (2004) found that men were more likely than females to believe
that risk factors caused hypertension.
In summary, the results indicate that out of the nine subscales of the IPQ-R, most
had no statistically significant association with medication adherence, and for the three
that demonstrated significant correlations with medication adherence (Consequences,
Emotional Representation, and Cyclical Timeline), only perceptions about consequences
of hypertension significantly predicted medication adherence. Stronger beliefs that
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hypertension causes a negative burden on life predicted better medication adherence.
Additionally, men are more likely to believe that lifestyle choices and uncontrollable
factors cause hypertension than women. Even though most studies about hypertension
perceptions and medication adherence among Black adults have been based on studies
with majority-female samples, the result of the present study suggests that Black males
likely hold about the same views as Black females.
Strengths. The major strength of the present study is that sample was
homogenous with respect to access to primary care in that all participants were
established patients in one of four primary care settings. An important strength of the
PCA conducted in the current study is that explicit a priori criteria were used in deciding
how items were selected, unlike the two previous studies that conducted PCA on the 18
causal items of the IPQ-R (Pickett et al., 2014; Moss-Morris et al., 2002). These two
previous studies did not give a clear report on how factors were selected or how crossloadings were handled. Additionally, the two factors extracted in the current study
demonstrated acceptable evidence of internal consistency reliability. The sample, though
more educated than the usually lower-educated samples often seen in studies of Black
adults, were recruited from multiple clinics that serve a lower-to-middle-class Black adult
patient population, thus increasing the chance that the target population was recruited. In
contrast with the present study’s sample, the sample in Pickett et al. (2014) recruited
participants with lower educational levels from shopping malls, community housing, and
clinics, while the sample in Moss-Morris et al. (2002) included individuals with various
types of chronic medical illnesses other than hypertension who were recruited from both
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inpatient and outpatient settings in Europe. Using a chart review to confirm diagnosis of
primary/essential hypertension was also a strength.
Additionally, this is one of the few studies that measured hypertension
perceptions and medication adherence quantitatively and used standardized
questionnaires. To the author’s knowledge, the current study is the second study within
the last 10 years that has examined the impact of perceptions of hypertension on
antihypertensive use. The present study, however, is the first to report an association
between consequences and medication adherence among Black hypertensive adults.
Furthermore, the present study has partially presented evidence that Black hypertensive
males and females may hold the same perceptions regarding hypertension.
Limitations. The present study is not without limitations. Misclassification of
medication adherence or illness perceptions is likely a limitation of this study due to the
use of self-report questionnaires to measure hypertension perceptions and medication
adherence. Self-report questionnaires may lead to participants’ overestimation of
adherence, recall bias, and likelihood for giving socially acceptable responses (Morisky
et al., 2008). Because of the use of a cross-sectional design in this study, cause and effect
cannot be ascertained. Another important limitation is the inability to address the impact
of acculturation on hypertension perceptions and/or medication adherence, especially for
foreign-born Blacks. However, the current study’s focus was not strictly on a foreignborn sample of Black hypertensive population. Finally, not measuring depression with a
standardized instrument was also a limitation of this study.
Implication. The findings of this study are generalizable to Black hypertensive
adults 35 to 65 years old, most of whom had a high school education or higher, in
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primary care settings. The findings of this study, especially as it relates to perceptions
about cause of hypertension, revealed that Black adults hold ambivalent views about
what factors cause hypertension, however, this sample seem to lean toward a belief that
hypertension is caused by a combination of psychological/life stressors and known risks
factors for hypertension. Furthermore, in this study, perceptions that hypertension is a
disease with consequences or burden was found to be significantly associated with
medication adherence.
These findings highlight the need for clinicians and nurse educators to frequently
assess patients’ perceptions about their hypertension, educating and correcting any
misconceptions the patient may have. Since knowing that strongly believing that
hypertension has complications is associated with better medication adherence, nurses
that take care of Black adults with hypertension should frequently highlight the
importance of medication adherence as a means to reduce complications and the general
health burden of uncontrolled hypertension, especially at the time of diagnosis and at
every encounter in the healthcare setting. Exploring patients’ perceptions of hypertension
presents clinicians with an important opportunity to correct misconceptions about the
disease. Assessing patients’ perceptions about their hypertension creates an opportunity
for the clinicians to identify patients that may have poor outcome from hypertension
earlier on so that interventions can be initiated.
Despite the limitations discussed above, there is value in the knowledge gained,
and the results will inform the design of a longitudinal study with a larger sample size
that could further examine and clarify hypertension beliefs and its role in medication
adherence among Black hypertensive adults. Further recommendation for future study in
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this area could focus on exploring the role of acculturation on hypertension perceptions
and medication adherence among foreign-born hypertensive Black adults residing in the
United States. Future studies should also explore how perceptions of hypertension differ
by blood pressure control status.

Conclusion
This study has demonstrated that illness perceptions, especially perception that
hypertension places a burden on one’s life, is related to medication adherence among
Black hypertensive adults aged 35 to 65 years. This study’s results further established
that there is ambivalence among Black hypertensive adults regarding whether the
combination of life stressors and known hypertension risk factors are causes of
hypertension; however, it is also clear in this study that the sample did not agree that
hypertension is caused by factors not generally accepted as risk factors by the medical
community. Although men and women are very similar in reports of their medication
adherence and their perceptions of hypertension, men are more likely than women to
attribute cause of hypertension to unhealthy lifestyle choices and influences outside an
individual’s control.
A well-thought out and designed intervention is needed to improve perceptions
about hypertension and better disease control among Black hypertensive adults; however,
more studies, such as a repeat of the present one with larger sample sizes, are needed to
elicit more knowledge and understanding of hypertension perceptions, including
consequences, and their impact on medication adherence or general self-care
management behaviors among Black hypertensive adults.
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There is a need for future research to focus on populations with the highest
prevalence of uncontrolled hypertension and its complications (Levine et al., 2011).
Targeting Black hypertensive adults between the ages of 35 to 65 years for interventions
to improve understanding of hypertension and promote medication adherence will help in
forestalling potential future negative outcomes that could emanate from uncontrolled
hypertension among Black hypertensive adults. Although no specific intervention has
been ascertained to be a lasting solution to the problem of poor blood pressure control
among the Black adult population, it is likely that interventions that are designed to
address all or most of the factors implicated in the poor blood pressure control in the
Black adult population may provide a lasting solution to this problem.
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PROVISIONS: This approval relates to the research to be
conducted under the above referenced title and/or to any
associated materials considered by the Committee for the
Protection of Human Subjects, e.g. study documents, informed
consent, etc.
APPROVED:

By Expedited Review and Approval

REVIEW DATE:

10/23/2017

APPROVAL DATE: 10/23/2017
EXPIRATION DATE:
CHAIRPERSON:

09/30/2018

L. Maximilian Buja, MD

Subject to any provisions noted above, you may now begin this research.
CHANGES: The principal investigator (PI) must receive approval from the
CPHS before initiating any changes, including those required by the
sponsor, which would affect human subjects, e.g. changes in methods or
procedures, numbers or kinds of human subjects, or revisions to the
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informed consent document or procedures. The addition of coinvestigators must also receive approval from the CPHS.
ALL PROTOCOL REVISIONS MUST BE SUBMITTED TO THE
SPONSOR OF THE RESEARCH.
INFORMED CONSENT DETERMINATION:
Signed Informed Consent Required
INFORMED CONSENT: When Informed consent is required, it must be obtained by the PI or
designee(s), using the format and procedures approved by the CPHS. The PI is responsible
to instruct the designee in the methods approved by the CPHS for the consent process. The
individual obtaining informed consent must also sign the consent document. Please note that
only copies of the stamped approved informed consent form can be used when obtaining
consent.

HEALTH INSURANCE PORTABILITY and ACCOUNTABILITY ACT
(HIPAA):
HIPAA Authorization required:
HIPAA Authorization within consent form

UNANTICIPATED RISK OR HARM, OR ADVERSE DRUG
REACTIONS: The PI will immediately inform the CPHS of any
unanticipated problems involving risks to subjects or others, of any
serious harm to subjects, and of any adverse drug reactions.

RECORDS: The PI will maintain adequate records, including
signed consent and HIPAA documents if required, in a manner that
ensures subject confidentiality.
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University of Texas Health Science Center at Houston/Memorial Hermann Healthcare
System
INFORMED CONSENT FORM TO TAKE PART IN RESEARCH
Protocol Title: Association of Illness Perceptions and Antihypertensive Medication
Adherence Among Black Hypertensive Adults in Primary Care Setting
HSC-SN-17-0872
INVITATION TO TAKE PART
You are invited to take part in a research project called, “Association of illness
perception and medication adherence among Black hypertensive adults in primary care
settings” conducted by STELLA EKE, of the University of Texas Health Science Center
at Houston (UTHealth). For this research project, I will be called the Principal
Investigator or PI.
Your decision to take part in this study is voluntary. You may refuse to take part
or choose to stop taking part at any time. A decision not to take part or to stop being a
part of the research project will not change the services available to you from your
doctors, other healthcare providers at this clinic, and research staff with the University of
Texas Health Science Center at Houston. Your participation in this study is completely
voluntary. You may discontinue your participation in the study at any time while
completing the survey without any penalty, and it will not affect your care.
You may refuse to answer any questions asked or written on any forms. This
research project has been reviewed by the Committee for the Protection of Human
Subjects (CPHS) of the University of Texas Health Science Center at Houston as HSCSN-17-0872
PURPOSE
Your participation is being requested for a dissertation research study by Stella
Eke, a Doctor of Philosophy(PhD) in Nursing student at University of Texas - Houston
Health Science Center. The purpose of this study is to examine the relationship between
perceptions about hypertension and medication adherence among Black hypertensive
adults 35 to 65 years, in primary care. Some studies have shown that Blacks or African
Americans have worse blood pressure control and suffer more severe complications from
hypertension than other races. The student is conducting a study to examine whether your
views or understanding about hypertension have any effect on the way you take your
blood pressure medication.
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PROCEDURES
If you agree and are able to take part in this study you will first sign the consent
form. After obtaining your consent, you will be asked to complete two questionnaires and
a demographic data form. After you complete the questionnaires, the PI will ask you for
your name and date of birth in order to review your chart/medical record. The purpose of
the chart review is only to verify your eligibility for the study and confirm some of the
responses on the demographic form. It is very important that you know that participating
in this study will in no way affect your care at this clinic. Your doctor or healthcare
provider will not have access to or know about your survey responses. The researcher
will not in any way share your completed survey with the clinic.

TIME COMMITMENT
The total amount of time you will be asked to be in this study is only the time it
takes you to complete the questionnaires. This study involves only one-time completion
of these questionnaires. Completing the questionnaires and demographic data form will
take a total of approximately 15 to 20 minutes or less. There will be no other visit or
meeting needed from you after you complete the questionnaires.

BENEFITS
You may receive no direct benefit from being in the study; however, your taking
part may help hypertensive patients like you get better in the future. The major general
benefit of this study is that it will help inform and support the design of useful
interventions that can help Black adults in controlling their blood pressure, thereby
reducing the risks for complications from uncontrolled hypertension.

RISKS AND/OR DISCOMFORTS
One of the possible risks to you as a participant in this study may relate to breach
of confidential information. However, in this study, confidentiality will be strictly
maintained to the extent allowable by law. To protect your privacy, the study has created
study identification numbers that will be written on the survey you completed instead of
your name; that way no one will know who completed the survey. Your name will not be
written on any survey you completed. Information collected is only for research purposes
and will not negatively impact your treatment or relationship with your healthcare
providers. Your doctor or any other medical team will also not have access to your survey
responses. The principal investigator (researcher), her school research advisor, and a
statistician are the only people that will have access to your data or survey responses.
Responses from the survey will be analyzed as a group and not on an individual basis.
Any unneeded information accidentally collected from you will be shredded
immediately; then the hard copies of the survey responses will be shredded one year from
the study completion date. In case the research gets published, no patient identifying
information will be included in the publication. The researcher will strive to prevent any
chance of injury or problem to you as you participate in this study and will be willing and
available to address any such issues if needed. However, University of Texas - Houston
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does not provide medical services or financial assistance for injuries sustained due to
your participation in this study.
Another potential risk will be fatigue because of the time you may spend
completing the questionnaires. You may take a break from this survey as often as you
want and resume it later.

ALTERNATIVES
You can also choose not to participate in this study as an alternative option to
participating in this study.

STUDY WITHDRAWALYour decision to take part is voluntary. You may decide to
stop taking part in the study at any time. A decision not to take part or to stop being a part
of the research project will not change the healthcare services available to you from your
doctor or other healthcare providers.

COSTS, REIMBURSEMENT AND COMPENSATION
If you decide to take part in this research study, there will be no cost to you as a
participant in this study; however, you will be given a $10 to $15 gift card to Walmart or
Starbucks in appreciation for your time and participation upon completion of the
questionnaires.
CONFIDENTIALITY
Please understand that representatives of the University of Texas Health Science
Center at Houston may review your research and/or medical records for the purposes of
verifying research data and will see personal identifiers. However, identifying
information will not appear on records retained. You will not be personally identified in
any reports or publications that may result from this study. There is a separate section in
this consent form that you will be asked to sign which details the use and disclosure of
your protected health information.

QUESTIONS
If you have questions at any time about this research study, please feel free to
contact the principal investigator (STELLA EKE) at 832-683-1540, as she will be glad to
answer your questions. You can contact the study team to discuss problems, voice
concerns, obtain information, and offer input in addition to asking questions about the
research.
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AUTHORIZATION TO USE AND DISCLOSE
PROTECTED HEALTH INFORMATION FOR RESEARCH

PATIENT NAME:_________________________________
DATE OF BIRTH:___________________
Protocol Number and Title: Association of Illness Perceptions and Antihypertensive
Medication Adherence Among Black Hypertensive Adults in Primary Care Setting. HSCSN-17-0872
Principal Investigator: STELLA EKE
By signing this document, you give permission to your doctor to disclose (release) your health
information that identifies you for the research study named above.
If you sign this document, you give permission to the researchers to obtain health information from the
following health care providers:

Name of Provider

Address of Provider

Fax Number of
Provider

Austin Williams, MD

Albert Oguejiofor, MD

7015 Almeda Rd suite 5, Houston

N/A. PI will be at the

TX 77054

clinic

7737 Beechnut suite 200 Houston

Same as above

TX 77036
Arnold Carothers, DO

17121 Westheimer Rd Houston

Same as above

TX 77082
UT-Health Clinic:

7000 Fannin suite 1620 Houston

Delorean Alexander, NP

TX 77030

Same as above

Angela Rutherford, NP
George Delclos, MD

The only identifying information will be your name and date of birth on the
signature page of this form, however, this form will be separated from your completed
survey. Your completed survey will be assigned a study number instead. Your consent
forms will be stored in a locked cabinet and destroyed one year after study completion.
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The purpose of the chart review is to verify eligibility for study participation.
Information to be collected from the medical record include blood pressure readings,
history of depression, duration of your high blood pressure, diagnosis of primary
hypertension, and age.
The health information listed above may be used by and/or disclosed (released) to
researchers and their staff. Your doctor is required by law to protect your health
information. By signing this document, you authorize your doctor to disclose your health
information for this research.
If all information that does or can identify you is removed from your health
information, the remaining information will no longer be subject to this authorization and
may be used or disclosed for other purposes. No publication or public presentation about
the research described above will reveal your identity without another authorization from
you.
Please note that health information used and disclosed may include information
relating to HIV infection; treatment for or history of drug or alcohol abuse; or mental,
behavioral health, or psychiatric care.
Also note that you do not have to sign this Authorization, but if you do not, you
may not participate in this research study. Your doctor may not withhold treatment or
refuse treating you if you do not sign this Authorization.
You may change your mind and revoke (take back) this Authorization at any time.
Even if you revoke this Authorization, researchers may still use or disclose health
information they already have obtained about you as necessary to maintain the integrity
or reliability of the current research.
PI Name: STELLA EKE
The University of Texas Health Science Center at
Houston
Address: 6901 BERTNER AVE Houston TX
77030
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SIGNATURES
Sign below only if you understand the information given to you about this
research and you choose to take part. Make sure that any questions have been answered
and that you understand the study. If you have any questions or concerns about your
rights as a research subject, call the Committee for the Protection of Human Subjects at
(713) 500-7943. You may also call the Committee if you wish to discuss problems,
concerns, and questions; obtain information about the research; and offer input about
current or past participation in a research study. If you decide to take part in this research
study, a copy of this signed consent form will be given to you.

Printed Name of Subject

Signature of Subject

Date

Printed Name of Person

Signature of Person

Date

Obtaining Informed

Obtaining Informed

Consent

Consent

This study HSC-SN-17-0872 has been reviewed by the Committee for the Protection of
Human Subjects (CPHS) of the University of Texas Health Science Center at Houston.
For any questions about research subject's rights, or to report a research-related injury,
call the CPHS at (713) 500-7943.
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Black/African-American Hypertensive Adult
Volunteers Needed for Research Study
A PhD in nursing student at University of Texas - Houston is
conducting a dissertation study to investigate the relationship between
hypertension perceptions and blood pressure medication adherence. This
study will be conducted by Ms. Stella Eke under the supervision of her
academic advisor at The University of Texas Health Science Center Houston School of Nursing.
You may be eligible to participate in this study if you are:




Black/African-American adult- male or female-35 to 65 years.
Have hypertension
Ever been prescribed blood pressure medication by your doctor-whether
you are taking it or not.

Study details/Procedure:
If you volunteer to participate in this study, you will be asked to complete a
one-time questionnaire related to the study, which would take
approximately 15-20 minutes to complete.
Compensation for your time will be provided.
Location: At this clinic location
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Do you think you may be interested?
For more information about the study, or to volunteer for this study,
please contact:
STELLA EKE ; Phone Number: 832-683-1540

The study has been reviewed and approved by the Research Ethics Committee at
UTHealth
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Illness Perception Questionnaire
We are interested in your own personal views of how you now see your current illness.
Please indicate how much you agree or disagree with the following statements about your
illness by ticking the appropriate box.
VIEWS ABOUT
YOUR HIGH
BLOOD
PRESSURE
IP1

IP2

IP3

IP4

IP5

IP6

IP7

IP8

IP9

IP10

My high blood
pressure will last a
short time
My high blood
pressure is likely to
be permanent rather
than temporary
My high blood
pressure will last for
a long time
This high blood
pressure will pass
quickly
I expect to have my
high blood pressure
for the rest of my
life
My high blood
pressure is a serious
condition
My high blood
pressure has major
consequences on my
life
My high blood
pressure does not
have much effect on
my life
My high blood
pressure strongly
affects the way
others see me
My high blood
pressure has serious
financial
consequences

Strongly
Disagree

Disagree

Neither
Agree Nor
Disagree

Agree

Strongly
Agree
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VIEWS ABOUT
YOUR HIGH
BLOOD
PRESSURE
IP11

IP12

IP13

IP14

IP15

IP16

IP17

IP18

IP19

IP20

IP21

IP22

My high blood
pressure causes
difficulties for those
who are close to me
There is a lot which
I can do to control
my symptoms
What I do can
determine whether
my high blood
pressure gets better
or worse
The course of my
high blood pressure
depends on me
Nothing I do will
affect my high
blood pressure
I have the power to
influence my high
blood pressure
My actions will
have no affect on
the outcome of my
high blood pressure
My high blood
pressure will
improve in time
There is very little
that can be done to
improve my high
blood pressure
My treatment will
be effective in
curing my high
blood pressure
The negative effects
of my high blood
pressure can be
prevented (avoided)
by my treatment
My treatment can
control my high
blood pressure

Strongly
Disagree

Disagree

Neither
Agree nor
Disagree

Agree

Strongly
Agree
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VIEWS
ABOUT
YOUR HIGH
BLOOD
PRESSURE
IP23

IP24

IP25

IP26

IP27

IP28

IP29

IP30

IP31

IP32

IP33

There is nothing
which can help my
condition
The symptoms of
my condition are
puzzling to me
My high blood
pressure is a
mystery to me
I don’t understand
my high blood
pressure
My high blood
pressure doesn’t
make any sense to
me
I have a clear
picture or
understanding of
my condition
The symptoms of
my high blood
pressure change a
great deal from
day to day
My symptoms
come and go in
cycles
My high blood
pressure is very
unpredictable
I go through cycles
in which my high
blood pressure gets
better or worse
I get depressed
when I think about
my high blood
pressure

Strongly
Disagree

Disagree

Neither
Agree
Agree Nor
Disagree

Strongly
Agree
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VIEWS
ABOUT
YOUR HIGH
BLOOD
PRESSURE
IP34

IP35

IP36

IP37

IP38

When I think about
my high blood
pressure I get upset
My high blood
pressure makes me
feel angry
My high blood
pressure does not
worry me
Having this high
blood pressure
makes me feel
anxious
My high blood
pressure makes me
feel afraid

Strongly
Disagree

Disagree

Neither
Agree
Agree Nor
Disagree

Strongly
Agree
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CAUSES OF MY HIGH BLOOD PRESSURE
We are interested in what you consider may have been the cause of your illness.
As people are very different, there is no correct answer for this question. We are most
interested in your own views about the factors that caused your illness rather than what
others including doctors or family may have suggested to you. Below is a list of possible
causes for your illness. Please indicate how much you agree or disagree that they were
causes for you by ticking the appropriate box.

POSSIBLE CAUSES
C1
C2
C3
C4
C5
C6
C7
C8
C9
C10
C11
C12
C13
C14
C15
C16
C17
C18

Stress or worry
Hereditary - it runs in my family
A Germ or virus
Diet or eating habits
Chance or bad luck
Poor medical care in my past
Pollution in the environment
My own behavior
My mental attitude e.g. thinking about life
negatively
Family problems or worries caused my
high blood pressure
Overwork
My emotional state e.g. feeling down,
lonely, anxious, empty
Ageing
Alcohol
Smoking
Accident or injury
My personality
Altered immunity

STRONGLY
DISAGREE

DISAGREE

NEITHER
AGREE NOR
DISAGREE

AGREE

STRONGLY
AGREE
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Hill-Bone Blood Pressure Therapy Scale

(NA/not applicable / DK/don’t know)
1. How often do you forget to take your HBP medicine?
2. How often do you decide not to take your HBP medicine?
3. How often do you leave the pharmacy without obtaining
your prescribed pills?(due to long line, closure of clinic,
forgot
4. How often do you miss taking your HBP pills when you
feel sick?
5. How often do you run out of HBP pills?
6. How often do you skip your HBP medicine 1–3 days
before you go to the clinic?
7. How often do you miss taking your HBP pills when you
feel better?
8. How often do you take someone else’s HBP pills?
9. How often do you miss taking your HBP pills when you
care less?

Some
None of of
Most of
the
the All the Don’t
the
time
time
time
time know
1
1

2
2

3
3

4
4

9
9

1

2

3

4

9

1
1

2
2

3
3

4
4

9
9

1

2

3

4

9

1
1

2
2

3
3

4
4

9
9

1

2

3

4

9
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Demographic and Confounding Variable Data
1. Please write your age in years: _____________
2. Which option best fits your educational level?
a. Less than high school
b. High school
c. Some college or trade school
d. Four-year college or greater
3. What is your gender?
a. Male
b. Female
4. How long has it been since you were told by a doctor that you have high blood
pressure? ____________
5. Where would you say your systolic (top blood pressure) reading usually is?
a. 140-159
b. Greater or equal to 160
6. Where would you say your diastolic (bottom blood pressure) reading usually is?
a. 90-99
b. Greater or equal to 100
7. Do you experience any worrisome symptoms from your high blood pressure?
a. Yes
b. No
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8. Have you ever been diagnosed with depression by a doctor or do you take
medication prescribed by a doctor or other healthcare providers for depression?
a. Yes
b. No
9. Do you have health insurance plan that pays for your blood pressure medication
and doctor visit?
a. Yes
b. No
10. What is your employment status?
a. Employed
b. Unemployed
c. Retired
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Participant
Code
Number



Screening Eligible
Date

Ineligibility
Reasons

Questionnaires Completed
Consent
Signed

(Choose
IPQ-R
Demograp
Hill-Bone
numbers
hic
(Yes/
(DD/MM/YY) (Yes/No)
(Yes/No)
(Yes/No)
from the list
No)
(Yes/No)
below)

Investigator
Comments

Eligibility Criteria:

1. Black adult male and females—35 to 65 years
2. Diagnosis of primary hypertension for at least 12 months
3. Have been prescribed or is taking at least one hypertensive medication
4. Able to read and write in English.
 Ineligibility Reasons:
1. Secondary hypertension as supported by history of sleep apnea, renal artery
disease, stenosis, certain cardiovascular diseases, hyperthyroidism, pregnancy, or
adrenal gland tumor (pheochromocytoma)
2. Severe mental disorder that can hinder comprehension of instructions.
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Patient Study number___________________
1. Participant’s age in years___________
2. Diagnosis of Primary/Essential Hypertension (ICD-10 code: I10) ?: Yes or No
3. Duration of hypertension diagnosis? __________
4. Documented diagnosis of depression or taking antidepressant?

Yes No

5. Two most recent systolic blood pressure readings_____________
6. Two most recent diastolic blood pressure reading_____________
7. Duration of hypertension diagnosis_____________
8. Number of blood pressure medications_________
 Decision: Met inclusion Criteria? Yes

No

 If excluded, why (Write in)_________________________
 Or choose from exclusion criteria:
(a) Potential secondary hypertension as supported by history of sleep apnea, renal artery
disease, stenosis, certain cardiovascular diseases, hyperthyroidism, pregnancy, or adrenal
gland tumor (pheochromocytoma);
(b) Severe mental disorder that can hinder comprehension of instructions;
(c) Refusal to provide informed consent
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Introduction
The purpose of this manual is to provide a guideline for data collectors or
researchers. This document provides step-by-step instructions for the data collection
process and is intended for use, to reduce error during the data collection process.
Purpose of Study


To investigate perceptions about causes of hypertension among Black
hypertensive adults aged 35 to 65 years of age.



To examine the relationship between medication adherence and hypertension
perceptions as related to views about hypertension timeline, controllability,
consequences, emotional representation, illness coherence, and cause among
Black hypertensive adults 35 to 65 years old while controlling for depression,
educational level, duration of diagnosis, hypertension-related symptom, and
severity of hypertension.



To explore to what extent hypertension perceptions and medication adherence
differ by gender after controlling for confounder.

Study Setting and Population:
The population of interest for this study is Black hypertensive adults, aged 35 to
65 years old in primary care settings. Recruitment/data collection will occur in four
primary care clinics in Houston Metropolitan area. One of the clinics is a universityaffiliated employee health clinic.
Approvals and Permissions:
Study approval was obtained from University of Texas-Houston Health Science
Center Committee for the Protection of Human Subjects (CPHS). Written permission was
obtained from management at each of the four sites.
Role of Principal Investigator
The Principal Investigator (PI) assumes the responsibility for all aspects of the
study including proposal development and defense, screening and recruitment, data
collection, data management, data analysis, data interpretation, writing up the final results
and report, and presentation of findings. Furthermore, the PI serves as the coordinator of
communication and activities between the parties involved in the study.
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Assessing Eligibility
Inclusion Criteria: (a) self-identified Black adults; (b) males and females, aged 35 to 65
years; (c) diagnosis of primary/essential hypertension (diagnosis of essential
hypertension was confirmed by PI during chart review based on written diagnosis of
“essential or primary” HTN or ICD 10 code (I10) in patients’ charts); (d) duration of
hypertension diagnosis for at least 12 months; (e) had been prescribed or was taking at
least one hypertensive medication; (e) ability to read and write in English.
Exclusion criteria: (a) Secondary hypertension as supported by history of sleep apnea,
renal artery disease, stenosis, certain cardiovascular diseases, hyperthyroidism,
pregnancy, or adrenal gland tumor (pheochromocytoma) upon chart review, (b) severe
mental disorder hindering comprehension of instructions; (c) refusal to provide informed
consent.
Study Variables
Illness Perceptions. This will be measured with revised-illness perception questionnaire.
IPQ-R has two sections: Illness representation (IR) with 38 items; and the Cause section
with 18 items.
Medication Adherence: This variable will be measured with the nine-item medication
adherence subscale of the Hill-Bone Blood Pressure Therapy adherence scale.
Covariates and demographic data: Demographic data include age, employment status,
gender, health insurance status. Covariates include history depression, number of
hypertension medications, experience of worrisome hypertension symptoms, duration of
hypertension and hypertension severity. These data will be collected using a designed
demographic data form designed for this study. Chart review will also be used to collect
data on certain covariates.
Supplies Needed for Recruitment and Data Collection:









Copies of the recruitment flyers
Copies of IPQ-R, Hill-Bone and demographic data questionnaires
Copies of informed Consent forms
Enrollment Log
Copies of PI chart review form
Pencils or pens
Clip boards
Gift cards: Choice of Starbucks or Wal-Mart gift cards worth $15 each card.
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Study codes or Numbers
Large envelope to store completed questionnaires and PI chart review forms
Large envelope to store completed informed consent.
Recruitment Procedure:



Before initiation of data collection, the PI will first visit each of the four clinics
and go over the recruitment process and familiarize himself/herself with the
clinics.



PI will be present at the clinic three to four days a week, rotating between the
clinics.



Recruitment flyer needs to be placed in the lobbies and exam rooms at each of the
clinics.



All data collection will take place in the clinics’ lobbies as the patients wait to see
their doctors.



To maximize the likelihood of recruiting many participants each recruitment day,
the PI may need to ask the clinic scheduler or front desk staff the days many
patients that may likely qualify for the study are scheduled.

Data Collection Procedure


PI approaches potential participants in the clinics’ lobby with the recruitment
flyer and gives a brief introduction of the study.



Allow potential participants time to read the flyer and ask questions about the
study.



If participant is interested in participating, the PI gives them the informed consent
form with signature. Remind participant to thoroughly read the informed consent
and ask questions before signing, including introduction, benefit, compensation,
risk and confidentiality.



After consent is signed, have participants complete the study questionnaires.



Always protect participants’ privacy while collecting data in the lobby.



Upon completion of the questionnaires, PI needs to go through the questionnaires
for missing data; and have participant complete any missing information.
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Allow each participant to select a $15-dollar Wal-Mart or Starbucks gift card.



Every potential participant approached, whether eligible or not, should be logged
in the “Enrollment log” form and reason for ineligibility documented.
Post Questionnaire Completion:



Assign each participant’s completed questionnaire a study identification code;
and write the code on each page of the questionnaire.



Place each completed questionnaire in the large envelope.



Using each participant’s name and date of birth, ask the clinic medical assistant or
front desk secretary to pull the chart.



Conduct the chart review using the form labeled “PI’s chart review form” .



At the end of chart review, write each participant’s study identification code on
the chart review form, attach it to the completed Illness Perception and Hill-Bone
medication adherence questionnaires and demographic form, and place them in
the large envelope.



Be careful not to write any participant’s name or date of birth on any of the
completed questionnaires or chart review form.



Place the signed informed consent forms in a large envelope separate from the
one containing the completed questionnaires.



At the end of each recruitment day, count and document the number of remaining
gift cards.
Data Management:



The PI is responsible for management and storage of all collected data.



PI is responsible for entering the date in SPSS.



PI and advisor will verify accuracy of data entry.



Completed questionnaires and consent forms will be stored in a locked cabinet
throughout the study and for five years post study.
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Data Analysis


Data analysis will be conducted by PI with assistance of a statistician.



Conduct principal component factor analysis of the 18 causal items of the IPQ-R
to examine sample’s perceptions about causal attribution of hypertension.



Conduct multiple regression to investigate the association between illness
(hypertension) perceptions and medication adherence.



Conduct ANCOVA to explore gender differences in medication and adherence
and hypertension perceptions.
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Demographics and Covariates Codebook
Variable
Identification Code
Age
Educational level

SPSS Name
ID
Age
Education

Gender

Gender

How long diagnosed with
HTN
Average systolic BP

HTN duration

Average diastolic BP

DBP

Experience worrisome HTN
symptoms
Ever been diagnosed with
Depression or take medication
Health insurance for doctor
visit and medication
Employment status

HTN symptoms

HTN medication complexity

Number of HTN
medications

Recruitment site

Site

SBP

Depression history
Health insurance
Employment

Coding instructions
As in assigned study ID
Age in years
1 = less than high school
2 = high school
3 = some college or trade school
4 = four yr college or greater
1 = Males
2 = Females
Enter year (continuous)
1 = 140-159 (mild or stage 1)
2 = ≥160 (severe or stage 2)
3 = <140 (normal)
1 = 90-99 (mild or stage 1)
2 = ≥100 (severe or stage 2)
3 = <90 (normal)
1 = Yes
2 = No
1 = Yes
2 = No
1 = Yes
2 = No
1 = Employed
2 = Unemployed
3 = Retired
≤ 2 = Not complex
≥ 3 = Complex

1 = Mercy SW
2 = AOW
3 = FMCC
4 = UT-Health
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IPQ-R: IR (P1 to P38) coding
Variable
BP lasts a short time

SPSS label Coding Instruction
IP1
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
BP likely to be permanent than temporary IP2
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
BP last for a long time
IP3
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
This HBP will pass quickly
IP4
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
I expect to have BP rest of my life
IP5
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
BP is a serious condition
IP6
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
BP has major consequences
IP7
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
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Variable
BP doesn’t have much effect on my life

SPSS label
IP8

BP strongly affects the way people see
me

IP9

My BP has serious financial
consequences

IP10

My BP causes difficulties for those close
to me

IP11

There is a lot I can do to control my
symptoms

IP12

What I do can determine whether my BP
gets better or worse

IP13

The course of my BP depends on me

IP14

Coding Instruction
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
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Variable
Nothing I do will affect my HBP

SPSS label
IP15

I have the power to influence my HBP

IP16

My actions will have no effect on the
outcome of my HBP

IP17

My HBP will improve in time

IP18

There is very little that can be done to
improve my HBP

IP19

My treatment will be effective in curing
my HBP

IP20

The negative effects of my HBP can be
prevented by my treatment

IP21

Coding Instruction
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
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Variable
My treatment can control my HBP

SPSS label
IP22

There is nothing which can help my
condition

IP23

The symptoms of my condition are
puzzling to me

IP24

My HBP is a mystery to me

IP25

I don’t understand my HBP

IP26

My HBP doesn’t make any sense to me

IP27

I have a clear picture or understanding of
my condition

IP28

Coding Instruction
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
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Variable
SPSS label
The symptoms of my HBP change a great IP29
deal from day to day

My symptoms come and go in cycles

IP30

MY HBP is very unpredictable

IP31

I go through cycles in which my HBP
gets better or worse

IP32

I get depressed when I think about my
HBP

IP33

When I think about my HBP I get upset

IP34

My HBP makes me feel angry

IP35

Coding Instruction
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
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Variable
My HBP does not worry me

SPSS label Coding Instruction
IP36
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
Having this HBP makes me feel anxious IP37
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
My HBP makes me feel afraid
IP38
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
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Causal Attribution Coding
Variable
Stress or worry

SPSS label Coding Instruction
C1
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
Hereditary
C2
1= Strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
Germ or virus
C3
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
Diet or eating habits
C4
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
Chance or bad luck
C5
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
Poor medical care in my past C6
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
Pollution in the environment C7
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
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Variable
My own behavior

SPSS label
C8

My mental attitude

C9

Family problems or worries

C10

Overwork

C11

My emotional state(anxious,
feeling down, lonely,
empty)

C12

Ageing

C13

Alcohol

C14

Coding Instruction
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
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Variable
Smoking

SPSS label
C15

Accident or injury

C16

My personality

C17

Altered immunity

C18

Coding Instruction
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
1= strongly disagree
2= disagree
3= neither agree nor disagree
4= agree
5= strongly agree
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Hill-Bone HBP scale Codebook
Variable
Forget to take BP
medicine

SPSS label
HBHBPmed 1

Decide not to take your
HBP medicine

HBHBPmed 2

Leave pharmacy
without picking
medicine

HBHBPmed 3

Miss taking HBP
medicine when feel sick

HBHBPmed 4

Run out of HBP pills

HBHBPmed 5

Skip HBP medicine for
1-3 days before going to
clinic

HBHBPmed 6

Miss taking BP pills
when feel better

HBHBPmed 7

Take someone else’s
HBP pills

HBHBPmed 8

Miss taking your HBP
pills when you care less

HBHBPmed 9

Coding Instruction
1= none of the time
2= some of the time
3= most of the time
4= all the time
1= none of the time
2= some of the time
3= most of the time
4= all the time
1= none of the time
2= some of the time
3= most of the time
4= all the time
1= none of the time
2= some of the time
3= most of the time
4= all the time
1= none of the time
2= some of the time
3= most of the time
4= all the time
1= none of the time
2= some of the time
3= most of the time
4= all the time
1= none of the time
2= some of the time
3= most of the time
4= all the time
1= none of the time
2= some of the time
3= most of the time
4= all the time
1= none of the time
2= some of the time
3= most of the time
4= all the time
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